{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":24,"items":[{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T04:11:36Z","timestamp":1574309496992},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2009,7,4]],"date-time":"2009-07-04T00:00:00Z","timestamp":1246665600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1007\/s00774-009-0105-3","type":"journal-article","created":{"date-parts":[[2009,7,3]],"date-time":"2009-07-03T03:20:44Z","timestamp":1246591244000},"page":"108-110","source":"Crossref","is-referenced-by-count":0,"title":["Normochromic normocytic anemia in a postmenopausal woman with severe osteoporosis treated with intermittent parathyroid hormone"],"prefix":"10.1007","volume":"28","author":[{"given":"Athanasios D.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"Mattheos","family":"Savvides","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Georgopoulos","sequence":"additional","affiliation":[]},{"given":"Sideris","family":"Delaroudis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,7,4]]},"reference":[{"key":"105_CR1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1001\/archinte.1977.03630170020008","volume":"137","author":"M Boxer","year":"1977","unstructured":"Boxer M, Ellman L, Geller R, Wang CA (1977) Anemia in primary hyperparathyroidism. Arch Intern Med 137:588\u2013593","journal-title":"Arch Intern Med"},{"key":"105_CR2","first-page":"1016","volume":"104","author":"RJ McGonigle","year":"1984","unstructured":"McGonigle RJ, Wallin JD, Husserl F, Deftos LJ, Rice JC, O\u2019Neill WJ, Fisher JW (1984) Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure. J Lab Clin Med 104:1016\u20131026","journal-title":"J Lab Clin Med"},{"key":"105_CR3","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1172\/JCI110154","volume":"67","author":"D Meytes","year":"1981","unstructured":"Meytes D, Bogin E, Ma A, Dukes PP, Massry SG (1981) Effect of parathyroid hormone on erythropoiesis. J Clin Invest 67:1263\u20131269","journal-title":"J Clin Invest"},{"key":"105_CR4","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.surg.2008.07.026","volume":"144","author":"JA Trunzo","year":"2008","unstructured":"Trunzo JA, McHenry CR, Schulak JA, Wilhelm SM (2008) Effect of parathyroidectomy on anemia and erythropoietin dosing in end-stage renal disease patients with hyperparathyroidism. Surgery (St. Louis) 144:915\u2013918","journal-title":"Surgery (St. Louis)"},{"key":"105_CR5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","volume":"146","author":"SA Greenspan","year":"2007","unstructured":"Greenspan SA, Bone HA, Ettinger MA, Hanley DA, Lindsay R, Zanchetta JA, Blosch CA, Mathisen AA, Morris SA, Marriott TA (2007) Effect of recombinant human parathyroid hormone (1\u201384) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial. Ann Intern Med 146:326\u2013339","journal-title":"Ann Intern Med"},{"key":"105_CR6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","volume":"344","author":"RM Neer","year":"2001","unstructured":"Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH (2001) Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434\u20131441","journal-title":"N Engl J Med"},{"key":"105_CR7","first-page":"613","volume":"102","author":"F Delwiche","year":"1983","unstructured":"Delwiche F, Garrity MJ, Powell JS, Robertson RP, Adamson JW (1983) High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis. J Lab Clin Med 102:613\u2013620","journal-title":"J Lab Clin Med"},{"key":"105_CR8","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/ndt\/13.8.2088","volume":"13","author":"A Komatsuda","year":"1998","unstructured":"Komatsuda A, Hirokawa M, Haseyama T, Horiuchi T, Wakui H, Imai H, Miura AB (1998) Human parathyroid hormone does not influence human erythropoiesis in vitro. Nephrol Dial Transplant 13:2088\u20132091","journal-title":"Nephrol Dial Transplant"},{"key":"105_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000185910","volume":"55","author":"D Meytes","year":"1990","unstructured":"Meytes D, Shacked N, Blum M, Ramot B (1990) Effect of excess parathyroid hormone on human bone marrow fibroblasts. Nephron 55:6\u20139","journal-title":"Nephron"}],"container-title":["Journal of Bone and Mineral Metabolism"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0105-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-009-0105-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0105-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:14:25Z","timestamp":1559110465000},"score":1.0,"issued":{"date-parts":[[2009,7,4]]},"references-count":9,"journal-issue":{"published-print":{"date-parts":[[2010,1]]},"issue":"1"},"alternative-id":["105"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00774-009-0105-3","relation":{"cites":[]},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T19:01:35Z","timestamp":1574276495450},"reference-count":4,"publisher":"Elsevier BV","issue":"5","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1016\/j.mehy.2008.12.019","type":"journal-article","created":{"date-parts":[[2009,1,22]],"date-time":"2009-01-22T09:35:55Z","timestamp":1232616955000},"page":"610","source":"Crossref","is-referenced-by-count":1,"title":["Insulin resistance and therapy: Cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways"],"prefix":"10.1016","volume":"72","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Medical Hypotheses"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987708006592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987708006592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T12:32:11Z","timestamp":1558096331000},"score":1.0,"issued":{"date-parts":[[2009,5]]},"references-count":4,"journal-issue":{"published-print":{"date-parts":[[2009,5]]},"issue":"5"},"alternative-id":["S0306987708006592"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2008.12.019","ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T08:07:18Z","timestamp":1574323638409},"reference-count":66,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Endocrinology & Metabolism"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1586\/eem.09.35","type":"journal-article","created":{"date-parts":[[2009,9,17]],"date-time":"2009-09-17T16:20:50Z","timestamp":1253204450000},"page":"423-434","source":"Crossref","is-referenced-by-count":8,"title":["Paget\u2019s disease of bone: emphasis on treatment with zoledronic acid"],"prefix":"10.1586","volume":"4","author":[{"given":"Stergios A","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","author":"Cundy","volume":"19","first-page":"246","year":"2008","journal-title":"Trends Endocrinol. Metab.","DOI":"10.1016\/j.tem.2008.06.001","doi-asserted-by":"crossref"},{"key":"CIT0002","author":"Ralston","volume":"372","first-page":"155","year":"2008","journal-title":"Lancet","DOI":"10.1016\/S0140-6736(08)61035-1","doi-asserted-by":"crossref"},{"key":"CIT0003","author":"Hocking","volume":"11","first-page":"2735","year":"2002","journal-title":"Hum. Mol. Genet.","DOI":"10.1093\/hmg\/11.22.2735","doi-asserted-by":"crossref"},{"key":"CIT0004","author":"Xu","volume":"20","first-page":"7","year":"2009","journal-title":"Cytokine Growth Factor Rev.","DOI":"10.1016\/j.cytogfr.2008.11.007","doi-asserted-by":"crossref"},{"key":"CIT0005","DOI":"10.1016\/j.bone.2006.08.003","doi-asserted-by":"publisher"},{"key":"CIT0006","author":"Polyzos","year":"2009","journal-title":"Horm. Metab. Res."},{"key":"CIT0007","DOI":"10.1002\/art.10834","doi-asserted-by":"publisher"},{"key":"CIT0008","DOI":"10.1016\/j.bone.2004.11.004","doi-asserted-by":"publisher"},{"key":"CIT0009","author":"Naot","volume":"22","first-page":"298","year":"2007","journal-title":"J. Bone Miner. Res.","DOI":"10.1359\/jbmr.061108","doi-asserted-by":"crossref"},{"key":"CIT0010","author":"Marshall","volume":"42","first-page":"965","year":"2009","journal-title":"Clin. Biochem.","DOI":"10.1016\/j.clinbiochem.2009.04.007","doi-asserted-by":"crossref"},{"key":"CIT0011","author":"Cooper","volume":"21","first-page":"3","year":"2006","journal-title":"J. Bone Miner. Res.","DOI":"10.1359\/jbmr.06s201","doi-asserted-by":"crossref"},{"key":"CIT0012","author":"Cundy","volume":"21","first-page":"9","year":"2006","journal-title":"J. Bone Miner. Res.","DOI":"10.1359\/jbmr.06s202","doi-asserted-by":"crossref"},{"key":"CIT0013","author":"Bolland","volume":"22","first-page":"411","year":"2007","journal-title":"J. Bone Miner. Res.","DOI":"10.1359\/jbmr.061204","doi-asserted-by":"crossref"},{"key":"CIT0014","author":"Walsh","volume":"42","first-page":"1219","year":"2008","journal-title":"Bone","DOI":"10.1016\/j.bone.2008.01.024","doi-asserted-by":"crossref"},{"key":"CIT0015","author":"Wermers","volume":"23","first-page":"819","year":"2008","journal-title":"J. Bone Miner. Res.","DOI":"10.1359\/jbmr.080215","doi-asserted-by":"crossref"},{"key":"CIT0016","author":"Langston","volume":"80","first-page":"1","year":"2007","journal-title":"Calcif. Tissue Int.","DOI":"10.1007\/s00223-006-0184-2","doi-asserted-by":"crossref"},{"key":"CIT0017","author":"Reid","volume":"35","first-page":"224","year":"2004","journal-title":"Bone","DOI":"10.1016\/j.bone.2004.03.023","doi-asserted-by":"crossref"},{"key":"CIT0018","author":"Shankar","volume":"21","first-page":"22","year":"2006","journal-title":"J. Bone Miner. Res.","DOI":"10.1359\/jbmr.06s204","doi-asserted-by":"crossref"},{"key":"CIT0019","author":"Devogelaer","volume":"19","first-page":"1109","year":"2008","journal-title":"Osteoporos. Int.","DOI":"10.1007\/s00198-008-0629-8","doi-asserted-by":"crossref"},{"key":"CIT0020","author":"Deftos","volume":"353","first-page":"872","year":"2005","journal-title":"N. Engl. J. Med.","DOI":"10.1056\/NEJMp058184","doi-asserted-by":"crossref"},{"key":"CIT0021","author":"Siris","volume":"21","first-page":"294","year":"2006","journal-title":"J. Bone Miner. Res.","DOI":"10.1359\/jbmr.06s218","doi-asserted-by":"crossref"},{"key":"CIT0022","author":"Colina","volume":"28","first-page":"1069","year":"2008","journal-title":"Rheumatol. Int.","DOI":"10.1007\/s00296-008-0640-6","doi-asserted-by":"crossref"},{"key":"CIT0023","author":"Widler","volume":"45","first-page":"3721","year":"2002","journal-title":"J. Med. Chem.","DOI":"10.1021\/jm020819i","doi-asserted-by":"crossref"},{"key":"CIT0024","author":"Russell","volume":"1068","first-page":"367","year":"2006","journal-title":"Ann. NY Acad. Sci.","DOI":"10.1196\/annals.1346.041","doi-asserted-by":"crossref"},{"key":"CIT0025","DOI":"10.1177\/154405910708601102","doi-asserted-by":"publisher"},{"key":"CIT0026","author":"Altman","volume":"289","first-page":"1379","year":"1973","journal-title":"N. Engl. J. Med.","DOI":"10.1056\/NEJM197312272892601","doi-asserted-by":"crossref"},{"key":"CIT0027","author":"Dunford","volume":"296","first-page":"235","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"CIT0028","author":"Nancollas","volume":"38","first-page":"617","year":"2006","journal-title":"Bone","DOI":"10.1016\/j.bone.2005.05.003","doi-asserted-by":"crossref"},{"key":"CIT0029","DOI":"10.1056\/NEJMoa044241","doi-asserted-by":"publisher"},{"key":"CIT0030","unstructured":"AACE Ad Hoc Task Force. American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines.Endocr. Pract.10(4), 353\u2013361 (2004).","DOI":"10.4158\/EP.10.4.353","doi-asserted-by":"crossref"},{"key":"CIT0031","DOI":"10.1007\/s002239900255","doi-asserted-by":"publisher"},{"key":"CIT0032","author":"Garnero","volume":"41","first-page":"354","year":"1998","journal-title":"Arthritis Rheum.","DOI":"10.1002\/1529-0131(199802)41:2<354::AID-ART20>3.0.CO;2-5","doi-asserted-by":"crossref"},{"key":"CIT0033","author":"Buckler","volume":"24","first-page":"81","year":"1999","journal-title":"Bone","DOI":"10.1016\/S8756-3282(99)00071-X","doi-asserted-by":"crossref"},{"key":"CIT0034","author":"Garnero","volume":"28","first-page":"461","year":"2001","journal-title":"Bone","DOI":"10.1016\/S8756-3282(01)00431-8","doi-asserted-by":"crossref"},{"key":"CIT0035","DOI":"10.1002\/art.21824","doi-asserted-by":"publisher"},{"key":"CIT0036","DOI":"10.1359\/jbmr.061001","doi-asserted-by":"publisher"},{"key":"CIT0037","author":"Patel","volume":"8","first-page":"1467","year":"1993","journal-title":"J. Bone Miner. Res.","DOI":"10.1002\/jbmr.5650081209","doi-asserted-by":"crossref"},{"key":"CIT0038","author":"Merlotti","volume":"22","first-page":"1510","year":"2007","journal-title":"J. Bone Miner. Res.","DOI":"10.1359\/jbmr.070704","doi-asserted-by":"crossref"},{"key":"CIT0039","author":"Avramidis","volume":"26","first-page":"635","year":"2008","journal-title":"J. Bone Miner. Metab.","DOI":"10.1007\/s00774-008-0852-6","doi-asserted-by":"crossref"},{"key":"CIT0040","author":"Chung","volume":"62","first-page":"275","year":"2003","journal-title":"Ann. Rheum. Dis.","DOI":"10.1136\/ard.62.3.275","doi-asserted-by":"crossref"},{"key":"CIT0041","author":"Tziomalos","volume":"25","first-page":"464","year":"2007","journal-title":"Clin. Exp. Rheumatol."},{"key":"CIT0042","author":"Tucci","volume":"14","first-page":"607","year":"2008","journal-title":"Endocr. Pract.","DOI":"10.4158\/EP.14.5.607","doi-asserted-by":"crossref"},{"key":"CIT0043","author":"Morton","volume":"64","first-page":"1386","year":"2005","journal-title":"Ann. Rheum. Dis.","DOI":"10.1136\/ard.2004.031302","doi-asserted-by":"crossref"},{"key":"CIT0044","author":"Pane","volume":"125","first-page":"1440","year":"2007","journal-title":"Arch. Ophthalmol.","DOI":"10.1001\/archopht.125.10.1440","doi-asserted-by":"crossref"},{"key":"CIT0045","author":"Oikonomou","volume":"32","first-page":"789","year":"2007","journal-title":"Spine","DOI":"10.1097\/BRS.0b013e31815b7eb8","doi-asserted-by":"crossref"},{"key":"CIT0046","unstructured":"Polyzos SA, Anastasilakis AD, Terpos E. Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.Support. Care CancerDOI: 10.1007\/s00520-009-0704-0705 (2009) (Epub ahead of print)."},{"key":"CIT0047","DOI":"10.1359\/jbmr.060712","doi-asserted-by":"publisher"},{"key":"CIT0048","DOI":"10.1200\/JCO.2005.02.8670","doi-asserted-by":"publisher"},{"key":"CIT0049","author":"Ruggiero","volume":"62","first-page":"527","year":"2004","journal-title":"J. Oral Maxillofac. Surg.","DOI":"10.1016\/j.joms.2004.02.004","doi-asserted-by":"crossref"},{"key":"CIT0050","author":"Gueiros","volume":"66","first-page":"1319","year":"2008","journal-title":"J. Oral Maxillofac. Surg.","DOI":"10.1016\/j.joms.2008.02.011","doi-asserted-by":"crossref"},{"key":"CIT0051","DOI":"10.1097\/01.mlg.0000187398.51857.3c","doi-asserted-by":"publisher"},{"key":"CIT0052","author":"Hay","volume":"102","first-page":"4","year":"2006","journal-title":"N. Z. Dent. J."},{"key":"CIT0053","author":"Terpos","volume":"20","first-page":"1303","year":"2009","journal-title":"Ann. Oncol.","DOI":"10.1093\/annonc\/mdn796","doi-asserted-by":"crossref"},{"key":"CIT0054","author":"Labinson","volume":"71","first-page":"269","year":"2007","journal-title":"Conn. Med."},{"key":"CIT0055","author":"Boyce","volume":"343","first-page":"1231","year":"1994","journal-title":"Lancet","DOI":"10.1016\/S0140-6736(94)92446-5","doi-asserted-by":"crossref"},{"key":"CIT0056","author":"Chang","volume":"349","first-page":"1676","year":"2003","journal-title":"N. Engl. J. Med.","DOI":"10.1056\/NEJMra022308","doi-asserted-by":"crossref"},{"key":"CIT0057","author":"Black","volume":"356","first-page":"1809","year":"2007","journal-title":"N. Engl. J. Med.","DOI":"10.1056\/NEJMoa067312","doi-asserted-by":"crossref"},{"key":"CIT0058","author":"Fromigue","volume":"25","first-page":"539","year":"2002","journal-title":"J. Endocrinol. Invest","DOI":"10.1007\/BF03345497","doi-asserted-by":"crossref"},{"key":"CIT0059","author":"Reinholz","volume":"60","first-page":"6001","year":"2000","journal-title":"Cancer Res."},{"key":"CIT0060","author":"Ebert","volume":"44","first-page":"858","year":"2009","journal-title":"Bone","DOI":"10.1016\/j.bone.2009.01.009","doi-asserted-by":"crossref"},{"key":"CIT0061","author":"Fujita","volume":"6","first-page":"71","year":"2007","journal-title":"Mol. Cancer","DOI":"10.1186\/1476-4598-6-71","doi-asserted-by":"crossref"},{"key":"CIT0062","author":"Krishnan","volume":"116","first-page":"1202","year":"2006","journal-title":"J. Clin. Invest.","DOI":"10.1172\/JCI28551","doi-asserted-by":"crossref"},{"key":"CIT0063","DOI":"10.1056\/NEJMra067395","doi-asserted-by":"publisher"},{"key":"CIT0064","author":"Tenta","volume":"40","first-page":"737","year":"2008","journal-title":"Horm. Metab. Res.","DOI":"10.1055\/s-2008-1078753","doi-asserted-by":"crossref"},{"key":"CIT0065","author":"Dass","volume":"6","first-page":"3263","year":"2007","journal-title":"Mol. Cancer Ther.","DOI":"10.1158\/1535-7163.MCT-07-0546","doi-asserted-by":"crossref"},{"key":"CIT0066","author":"Labrinidis","volume":"15","first-page":"3451","year":"2009","journal-title":"Clin. Cancer Res.","DOI":"10.1158\/1078-0432.CCR-08-1616","doi-asserted-by":"crossref"}],"container-title":["Expert Review of Endocrinology & Metabolism"],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/eem.09.35","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T18:01:34Z","timestamp":1558548094000},"score":1.0,"issued":{"date-parts":[[2009,9]]},"references-count":66,"journal-issue":{"published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2009,9]]},"issue":"5"},"alternative-id":["10.1586\/eem.09.35"],"URL":"http:\/\/dx.doi.org\/10.1586\/eem.09.35","relation":{"cites":[]},"ISSN":["1744-6651","1744-8417"],"issn-type":[{"value":"1744-6651","type":"print"},{"value":"1744-8417","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T08:44:43Z","timestamp":1574325883170},"reference-count":34,"publisher":"Mary Ann Liebert Inc","issue":"3","license":[{"URL":"https:\/\/www.liebertpub.com\/nv\/resources-tools\/text-and-data-mining-policy\/121\/","start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thyroid"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1089\/thy.2009.0157","type":"journal-article","created":{"date-parts":[[2009,9,28]],"date-time":"2009-09-28T19:20:47Z","timestamp":1254165647000},"page":"265-271","source":"Crossref","is-referenced-by-count":6,"title":["Alterations in Serum Thyroid\u2013Related Constituents After Thyroid Fine-Needle Biopsy: A Systematic Review"],"prefix":"10.1089","volume":"20","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[{"name":"Second Medical Clinic, Medical School, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece."}]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, 424 Military Hospital, Thessaloniki, Greece."}]}],"member":"278","container-title":["Thyroid"],"language":"en","link":[{"URL":"https:\/\/www.liebertpub.com\/doi\/full-xml\/10.1089\/thy.2009.0157","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.liebertpub.com\/doi\/pdf\/10.1089\/thy.2009.0157","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T23:08:01Z","timestamp":1535584081000},"score":1.0,"issued":{"date-parts":[[2010,3]]},"references-count":34,"journal-issue":{"published-print":{"date-parts":[[2010,3]]},"issue":"3"},"alternative-id":["10.1089\/thy.2009.0157"],"URL":"http:\/\/dx.doi.org\/10.1089\/thy.2009.0157","ISSN":["1050-7256","1557-9077"],"issn-type":[{"value":"1050-7256","type":"print"},{"value":"1557-9077","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T09:52:04Z","timestamp":1574329924825},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T00:00:00Z","timestamp":1256083200000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1007\/s00774-009-0131-1","type":"journal-article","created":{"date-parts":[[2009,10,20]],"date-time":"2009-10-20T19:21:05Z","timestamp":1256066465000},"page":"314-319","source":"Crossref","is-referenced-by-count":5,"title":["Serum homocysteine, folate and vitamin B12 in patients with Paget\u2019s disease of bone: the effect of zoledronic acid"],"prefix":"10.1007","volume":"28","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Zoe","family":"Efstathiadou","sequence":"additional","affiliation":[]},{"given":"Ioannis","family":"Litsas","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Kita","sequence":"additional","affiliation":[]},{"given":"Athanasios","family":"Panagiotou","sequence":"additional","affiliation":[]},{"given":"Athanasios","family":"Papatheodorou","sequence":"additional","affiliation":[]},{"given":"Georgios","family":"Arsos","sequence":"additional","affiliation":[]},{"given":"Efstratios","family":"Moralidis","sequence":"additional","affiliation":[]},{"given":"Georgios","family":"Barmpalios","sequence":"additional","affiliation":[]},{"given":"Efthimia","family":"Zafeiriadou","sequence":"additional","affiliation":[]},{"given":"Efthimia","family":"Triantafillidou","sequence":"additional","affiliation":[]},{"given":"Eleni","family":"Makrigiannaki","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2009,10,21]]},"reference":[{"key":"131_CR1","unstructured":"Polyzos SA, Anastasilakis AD, Terpos E (2009) Paget\u2019s disease of bone: emphasis on treatment with zoledronic acid . Expert Rev Endocrinol Metab 4:423\u2013434","DOI":"10.1586\/eem.09.35","doi-asserted-by":"crossref"},{"key":"131_CR2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(08)61035-1","volume":"372","author":"SH Ralston","year":"2008","unstructured":"Ralston SH, Langston AL, Reid IR (2008) Pathogenesis and management of Paget\u2019s disease of bone. Lancet 372:155\u2013163","journal-title":"Lancet"},{"key":"131_CR3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00774-006-0696-x","volume":"24","author":"S Takata","year":"2006","unstructured":"Takata S, Hashimoto J, Nakatsuka K, Yoshimura N, Yoh K, Ohno I, Yabe H, Abe S, Fukunaga M, Terada M, Zamma M, Ralston SH, Morii H, Yoshikawa H (2006) Guidelines for diagnosis and management of Paget\u2019s disease of bone in Japan. J Bone Miner Metab 24:359\u2013367","journal-title":"J Bone Miner Metab"},{"key":"131_CR4","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00198-008-0629-8","volume":"19","author":"JP Devogelaer","year":"2008","unstructured":"Devogelaer JP, Bergmann P, Body JJ, Boutsen Y, Goemaere S, Kaufman JM, Reginster JY, Rozenberg S, Boonen S (2008) Management of patients with Paget\u2019s disease: a consensus document of the Belgian Bone Club. Osteoporos Int 19:1109\u20131117","journal-title":"Osteoporos Int"},{"key":"131_CR5","unstructured":"Polyzos SA, Anastasilakis AD, Efstathiadou Z, Kita M, Litsas I, Avramidis A, Arsos G, Moralidis E, Gerou S, Pavlidou V, Papatheodorou A, Terpos E (2009) The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin and RANKL in patients with Paget\u2019s disease of bone. Horm Metab Res 41. doi: 10.1055\/s-0029-1233491 [Epub ahead of print]","DOI":"10.1055\/s-0029-1233491","doi-asserted-by":"crossref"},{"key":"131_CR6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/15648265080292S116","volume":"29","author":"J Selhub","year":"2008","unstructured":"Selhub J (2008) Public health significance of elevated homocysteine. Food Nutr Bull 29:116\u2013125","journal-title":"Food Nutr Bull"},{"key":"131_CR7","first-page":"1621","volume":"45","author":"M Herrmann","year":"2007","unstructured":"Herrmann M, Peter SJ, Umanskaya N, Wagner A, Taban-Shomal O, Widmann T, Colaianni G, Wildemann B, Herrmann W (2007) The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review. Clin Chem Lab Med 45:1621\u20131632","journal-title":"Clin Chem Lab Med"},{"key":"131_CR8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00296-008-0640-6","volume":"28","author":"M Colina","year":"2008","unstructured":"Colina M, La CR, De LF, Trotta F (2008) Paget\u2019s disease of bone: a review. Rheumatol Int 28:1069\u20131075","journal-title":"Rheumatol Int"},{"key":"131_CR9","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00774-008-0852-6","volume":"26","author":"A Avramidis","year":"2008","unstructured":"Avramidis A, Polyzos SA, Moralidis E, Arsos G, Efstathiadou Z, Karakatsanis K, Grollios G, Kita M (2008) Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget\u2019s disease of bone. J Bone Miner Metab 26:635\u2013641","journal-title":"J Bone Miner Metab"},{"key":"131_CR10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa044241","volume":"353","author":"IR Reid","year":"2005","unstructured":"Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget\u2019s disease. N Engl J Med 353:898\u2013908","journal-title":"N Engl J Med"},{"key":"131_CR11","unstructured":"Polyzos SA, Anastasilakis AD, Terpos E (2009) Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid. Support Care Cancer 17:1329\u20131330","DOI":"10.1007\/s00520-009-0704-5","doi-asserted-by":"crossref"},{"key":"131_CR12","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jbmr.5650110206","volume":"11","author":"SA Khan","year":"1996","unstructured":"Khan SA, McCloskey EV, Eyres KS, Nakatsuka K, Sirtori P, Orgee J, Coombes G, Kanis JA (1996) Comparison of three intravenous regimens of clodronate in Paget disease of bone. J Bone Miner Res 11:178\u2013182","journal-title":"J Bone Miner Res"},{"key":"131_CR13","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2008.10.051","volume":"44","author":"M Herrmann","year":"2009","unstructured":"Herrmann M, Tami A, Wildemann B, Wolny M, Wagner A, Schorr H, Taban-Shomal O, Umanskaya N, Ross S, Garcia P, Hubner U, Herrmann W (2009) Hyperhomocysteinemia induces a tissue specific accumulation of homocysteine in bone by collagen binding and adversely affects bone. Bone 44:467\u2013475","journal-title":"Bone"},{"key":"131_CR14","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1359\/jbmr.060406","volume":"21","author":"JM Koh","year":"2006","unstructured":"Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY, Lee KU, Kim GS (2006) Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21:1003\u20131011","journal-title":"J Bone Miner Res"},{"key":"131_CR15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00223-009-9244-8","volume":"84","author":"BL Vaes","year":"2009","unstructured":"Vaes BL, Lute C, Blom HJ, Bravenboer N, de Vries TJ, Everts V, Dhonukshe-Rutten RA, Muller M, de Groot LC, Steegenga WT (2009) Vitamin B(12) deficiency stimulates osteoclastogenesis via increased homocysteine and methylmalonic acid. Calcif Tissue Int 84:413\u2013422","journal-title":"Calcif Tissue Int"},{"key":"131_CR16","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/j.1582-4934.2008.00104.x","volume":"12","author":"M Herrmann","year":"2008","unstructured":"Herrmann M, Umanskaya N, Wildemann B, Colaianni G, Widmann T, Zallone A, Herrmann W (2008) Stimulation of osteoblast activity by homocysteine. J Cell Mol Med 12:1205\u20131210","journal-title":"J Cell Mol Med"},{"key":"131_CR17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1080\/00365510701342088","volume":"67","author":"S Ozdem","year":"2007","unstructured":"Ozdem S, Samanci S, Tasatargil A, Yildiz A, Sadan G, Donmez L, Herrmann M (2007) Experimental hyperhomocysteinemia disturbs bone metabolism in rats. Scand J Clin Lab Invest 67:748\u2013756","journal-title":"Scand J Clin Lab Invest"},{"key":"131_CR18","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/jama.293.9.1082","volume":"293","author":"Y Sato","year":"2005","unstructured":"Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293:1082\u20131088","journal-title":"JAMA"},{"key":"131_CR19","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/ajcn\/85.2.460","volume":"85","author":"TJ Green","year":"2007","unstructured":"Green TJ, McMahon JA, Skeaff CM, Williams SM, Whiting SJ (2007) Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial. Am J Clin Nutr 85:460\u2013464","journal-title":"Am J Clin Nutr"},{"key":"131_CR20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10654-009-9340-0","volume":"24","author":"L Ruan","year":"2009","unstructured":"Ruan L, Chen W, Srinivasan SR, Xu J, Toprak A, Berenson GS (2009) Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study. Eur J Epidemiol 24:315\u2013319","journal-title":"Eur J Epidemiol"},{"key":"131_CR21","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1001\/jama.1993.03510220049033","volume":"270","author":"J Selhub","year":"1993","unstructured":"Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH (1993) Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693\u20132698","journal-title":"JAMA"},{"key":"131_CR22","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1021\/bm050273s","volume":"6","author":"S Zhang","year":"2005","unstructured":"Zhang S, Wright JE, Bansal G, Cho P, Uludag H (2005) Cleavage of disulfide-linked fetuin-bisphosphonate conjugates with three physiological thiols. Biomacromolecules 6:2800\u20132808","journal-title":"Biomacromolecules"},{"key":"131_CR23","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0026-0495(94)90078-7","volume":"43","author":"ME Melton","year":"1994","unstructured":"Melton ME, Kochman ML (1994) Reversal of severe osteoporosis with vitamin B12 and etidronate therapy in a patient with pernicious anemia. Metabolism 43:468\u2013469","journal-title":"Metabolism"},{"key":"131_CR24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00296-008-0693-6","volume":"29","author":"I Bayhan","year":"2009","unstructured":"Bayhan I, Uygur D, Ugurlu N, Ozaksit G (2009) Strontium ranelate decreases plasma homocysteine levels in postmenopausal osteoporotic women. Rheumatol Int 29:263\u2013266","journal-title":"Rheumatol Int"},{"key":"131_CR25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bone.2004.03.023","volume":"35","author":"IR Reid","year":"2004","unstructured":"Reid IR, Davidson JS, Wattie D, Wu F, Lucas J, Gamble GD, Rutland MD, Cundy T (2004) Comparative responses of bone turnover markers to bisphosphonate therapy in Paget\u2019s disease of bone. Bone 35:224\u2013230","journal-title":"Bone"}],"container-title":["Journal of Bone and Mineral Metabolism"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0131-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-009-0131-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-009-0131-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:14:26Z","timestamp":1559110466000},"score":1.0,"issued":{"date-parts":[[2009,10,21]]},"references-count":25,"journal-issue":{"published-print":{"date-parts":[[2010,5]]},"issue":"3"},"alternative-id":["131"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00774-009-0131-1","relation":{"cites":[]},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T10:57:35Z","timestamp":1574333855630},"reference-count":193,"publisher":"Wiley","issue":"5","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1981,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"DOI":"10.1111\/j.1463-1326.2009.01176.x","type":"journal-article","created":{"date-parts":[[2009,11,6]],"date-time":"2009-11-06T08:46:07Z","timestamp":1257497167000},"page":"365-383","source":"Crossref","is-referenced-by-count":106,"title":["The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease"],"prefix":"10.1111","volume":"12","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Eleni","family":"Tsiaousi","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2010,3,30]]},"reference":[{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510290347","article-title":"Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease","volume":"29","author":"Caldwell","year":"1999","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2559.2006.02416.x","article-title":"Histological assessment of non-alcoholic fatty liver disease","volume":"49","author":"Hubscher","year":"2006","journal-title":"Histopathology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/CS20080253","article-title":"Metabolic disturbances in non-alcoholic fatty liver disease","volume":"116","author":"Byrne","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2036.2008.03703.x","article-title":"Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease","volume":"28","author":"Barshop","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB6|cit6","unstructured":"Ford ES Giles WH Mokdad AH. 2004 27 2444 2449","DOI":"10.2337\/diacare.27.10.2444","doi-asserted-by":"crossref"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cld.2004.04.006","article-title":"Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease","volume":"8","author":"Choudhury","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"72","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB9|cit9","unstructured":"Wilczynski NL Haynes RB. Robustness of empirical search strategies for clinical content in MEDLINE. Proceedings of the AMIA Symposium 2002 904 908"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u201chits\u201d?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1586\/17474124.2.5.705","article-title":"Role of nonalcoholic fatty liver disease in the development of insulin resistance and diabetes","volume":"2","author":"Gronbaek","year":"2008","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1007\/s10620-008-0585-3","article-title":"Adipose tissue: the new endocrine organ? a review article","volume":"54","author":"Wozniak","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00535-008-2193-6","article-title":"Liver diseases and metabolic syndrome","volume":"43","author":"Watanabe","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB16|cit16","first-page":"1083","article-title":"Adipokine interrelationship with the liver","volume":"64","author":"Takei","year":"2006","journal-title":"Nippon Rinsho"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2007.03586.x","article-title":"Adipokines and cytokines in non-alcoholic fatty liver disease","volume":"27","author":"Jarrar","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.cgh.2006.06.011","article-title":"Metabolic and adipokine profile of Chinese patients with nonalcoholic fatty liver disease","volume":"4","author":"Wong","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.20280","article-title":"Beyond insulin resistance in NASH: TNF-alpha or adiponectin?","volume":"40","author":"Hui","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","article-title":"The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1152\/ajpendo.00110.2003","article-title":"Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans","volume":"285","author":"Bruun","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB22|cit22","first-page":"127","article-title":"The multi-hit process and the antagonistic roles of tumor necrosis factor-alpha and adiponectin in nonalcoholic fatty liver disease","volume":"13","author":"Polyzos","year":"2009","journal-title":"Hippokratia"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/diacare.26.8.2442","article-title":"Adiponectin: more than just another fat cell hormone?","volume":"26","author":"Chandran","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1210\/en.2007-1561","article-title":"Plasma adiponectin complexes have distinct biochemical characteristics","volume":"149","author":"Schraw","year":"2008","journal-title":"Endocrinology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.phrs.2007.09.014","article-title":"Adiponectin circulating levels: a new emerging biomarker of cardiovascular risk","volume":"56","author":"Giannessi","year":"2007","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jhep.2005.08.019","article-title":"Up-regulation of the anti-inflammatory adipokine adiponectin in acute liver failure in mice","volume":"44","author":"Wolf","year":"2006","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1006\/bbrc.2001.5134","article-title":"Change in expression of GBP28\/adiponectin in carbon tetrachloride-administrated mouse liver","volume":"285","author":"Yoda-Murakami","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature01705","article-title":"Cloning of adiponectin receptors that mediate antidiabetic meta-bolic effects","volume":"423","author":"Yamauchi","year":"2003","journal-title":"Nature"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1210\/er.2006-0033","article-title":"Adipose tissue-derived factors: impact on health and disease","volume":"27","author":"Trujillo","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1172\/JCI29126","article-title":"Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome","volume":"116","author":"Kadowaki","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","article-title":"Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex","volume":"46","author":"Cnop","year":"2003","journal-title":"Diabetologia"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1038\/oby.2007.291","article-title":"Adiponectin and ghrelin levels and body size in normoglycemic Filipino, African-American, and white women","volume":"15","author":"Araneta","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/jc.2008-0425","article-title":"Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance","volume":"93","author":"Hivert","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.2009.976","article-title":"Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"302","author":"Li","year":"2009","journal-title":"JAMA"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB36|cit36","first-page":"20","article-title":"Adiponectin: lowering in metabolic syndrome and independent relation to hypertriglyceridemia","volume":"48","author":"Tanianskii","year":"2008","journal-title":"Kardiologiia"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.2337\/diacare.27.10.2450","article-title":"Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes","volume":"27","author":"Shetty","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jcem.87.5.8624","article-title":"Serum adiponectin and leptin levels in patients with lipodystrophies","volume":"87","author":"Haque","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.fertnstert.2004.11.077","article-title":"Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome","volume":"83","author":"Ardawi","year":"2005","journal-title":"Fertil Steril"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2143\/AC.63.2.2029522","article-title":"The association between plasma adiponectin level and hypertension","volume":"63","author":"Shankar","year":"2008","journal-title":"Acta Cardiol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"4733","DOI":"10.1371\/journal.pone.0004733","article-title":"Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques","volume":"4","author":"Broedl","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/MCA.0b013e3282f3c40b","article-title":"Impact of plasma adiponectin levels to the presence and severity of coronary artery disease in patients with metabolic syndrome","volume":"19","author":"Selcuk","year":"2008","journal-title":"Coron Artery Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB43|cit43","first-page":"55","article-title":"Adiponectin and resistin-new hormones of white adipose tissue","volume":"9","author":"Beltowski","year":"2003","journal-title":"Med Sci Monit"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi","year":"2002","journal-title":"Nat Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.21991","article-title":"High molecular weight adiponectin inhibits proliferation of hepatic stellate cells via activation of adenosine monophosphate-activated protein kinase","volume":"47","author":"Adachi","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbrc.2006.09.101","article-title":"Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitro","volume":"350","author":"Neumeier","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1053\/j.gastro.2006.05.054","article-title":"Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance","volume":"131","author":"Tilg","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2007.04.002","article-title":"Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences","volume":"47","author":"Leclercq","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1111\/j.1742-4658.2009.06955.x","article-title":"Full-length adiponectin protects hepatocytes from palmitate-induced apoptosis via inhibition of c-Jun NH terminal kinase","volume":"276","author":"Jung","year":"2009","journal-title":"FEBS J"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/en.2004-1572","article-title":"Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin","volume":"146","author":"Sennello","year":"2005","journal-title":"Endocrinology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1152\/ajpendo.90731.2008","article-title":"APPL1: role in adiponectin signaling and beyond","volume":"296","author":"Deepa","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1210\/jc.2004-2240","article-title":"Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity","volume":"90","author":"Bugianesi","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/gut.2003.037010","article-title":"Adiponectin and its receptors in non-alcoholic steatohepatitis","volume":"54","author":"Kaser","year":"2005","journal-title":"Gut"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1111\/j.1572-0241.2005.00297.x","article-title":"Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic Beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis","volume":"100","author":"Musso","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/01.mcg.0000152747.79773.2f","article-title":"Is adiponectin involved in the pathogenesis of nonalcoholic steatohepatitis? A preliminary human study","volume":"39","author":"Vuppalanchi","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/eje.1.01821","article-title":"Plasma adiponectin is decreased in nonalcoholic fatty liver disease","volume":"152","author":"Pagano","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"4287","DOI":"10.1210\/jc.2006-1010","article-title":"Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat","volume":"91","author":"Burgert","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.metabol.2007.06.013","article-title":"Regulation of adiponectin receptor expression in human liver and a hepatocyte cell line","volume":"56","author":"Shimizu","year":"2007","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1111\/j.1572-0241.2007.01322.x","article-title":"Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7 S level to predict the early stage of nonalcoholic steatohepatitis","volume":"102","author":"Shimada","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s11695-008-9506-y","article-title":"A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH)","volume":"18","author":"Younossi","year":"2008","journal-title":"Obes Surg"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB61|cit61","first-page":"355","article-title":"Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis.","volume":"71","author":"Arvaniti","year":"2008","journal-title":"Acta Gastro-Enterol Belg"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB62|cit62","first-page":"123","article-title":"Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis","volume":"8","author":"Munoz","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1007\/s10620-007-9981-3","article-title":"Influence of insulin resistance and adipokines in the grade of steatosis of nonalcoholic fatty liver disease","volume":"53","author":"Aller","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1365-2265.2006.02527.x","article-title":"Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/07853890801946515","article-title":"Association of liver disease with postprandial large intestinal triglyceride-rich lipoprotein accumulation and pro\/antioxidant imbalance in normolipidemic non-alcoholic steatohepatitis","volume":"40","author":"Musso","year":"2008","journal-title":"Ann Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1440-1746.2008.05548.x","article-title":"Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease","volume":"24","author":"Ma","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB67|cit67","first-page":"67","article-title":"Hepatic expression of ghrelin and adiponectin and their receptors in patients with nonalcoholic fatty liver disease","volume":"7","author":"Uribe","year":"2008","journal-title":"Ann Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1152\/ajpendo.00494.2003","article-title":"Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics","volume":"287","author":"Tietge","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2796.2005.01543.x","article-title":"Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis","volume":"258","author":"Kaser","year":"2005","journal-title":"J Intern Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1478-3231.2004.0986.x","article-title":"Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels","volume":"25","author":"Sohara","year":"2005","journal-title":"Liver Int"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB71|cit71","author":"Polyzos","year":"2009","article-title":"Non-linear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1572-0241.2008.01888.x","article-title":"Plasma adiponectin levels in primary biliary cirrhosis: a novel perspective for link between hypercholesterolemia and protection against atherosclerosis","volume":"103","author":"Floreani","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jhep.2004.12.024","article-title":"High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo","volume":"42","author":"Tacke","year":"2005","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1517\/14728220802658481","article-title":"Paradoxical role for adiponectin in chronic renal diseases? An example of reverse epidemiology","volume":"13","author":"Beige","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.nut.2008.07.020","article-title":"Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease","volume":"25","author":"Valentini","year":"2009","journal-title":"Nutrition"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/ard.2008.095737","article-title":"Increased serum adiponectin levels in female patients with erosive compared with non-erosive osteoarthritis","volume":"68","author":"Filkova","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10067-008-1074-y","article-title":"Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction","volume":"28","author":"Ebina","year":"2009","journal-title":"Clin Rheumatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.clinbiochem.2009.02.023","article-title":"Prognostic value of increased adiponectin plasma concentrations in patients with acute destabilized heart failure","volume":"42","author":"Dieplinger","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB79|cit79","author":"Celik","year":"2009","article-title":"Elevated adiponectin levels in patients with chronic heart failure: An independent predictor of mortality or a marker of cardiac cachexia?","journal-title":"Int J Cardiol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/eurjhf\/hfp046","article-title":"Adiponectin is increased in cardiac cachexia irrespective of body mass index","volume":"11","author":"Paulo","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.2003.02264.x","article-title":"Circulating adiponectin levels during human endotoxaemia","volume":"134","author":"Keller","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11695-008-9701-x","article-title":"Pattern of expression of adiponectin receptors in human liver and its relation to nonalcoholic steatohepatitis","volume":"19","author":"Nannipieri","year":"2009","journal-title":"Obes Surg"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/hep.22142","article-title":"Adiponectin gene polymorphisms modulate acute adiponectin response to dietary fat: Possible pathogenetic role in NASH","volume":"47","author":"Musso","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1007\/s00535-009-0085-z","article-title":"Influence of adiponectin gene polymorphisms in Japanese patients with non-alcoholic fatty liver disease","volume":"44","author":"Tokushige","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1007\/BF03345657","article-title":"Correlation between adiponectin polymorphisms and non-alcoholic fatty liver disease with or without metabolic syndrome in Chinese population","volume":"31","author":"Wang","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1478-3231.2007.01623.x","article-title":"Effect of peroxisome proliferator-activated receptors-gamma and co-activator-1alpha genetic polymorphisms on plasma adiponectin levels and susceptibility of non-alcoholic fatty liver disease in Chinese people","volume":"28","author":"Hui","year":"2008","journal-title":"Liver Int"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/hep.22659","article-title":"Transcription factor 7-like 2 polymorphism modulates glucose and lipid homeostasis, adipokine profile, and hepatocyte apoptosis in NASH","volume":"49","author":"Musso","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2350-10-15","article-title":"Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis","volume":"10","author":"Tong","year":"2009","journal-title":"BMC Med Genet"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP.10.4.353","article-title":"American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines","volume":"10","author":"AACE Ad Hoc Task Force","year":"2004","journal-title":"Endocr Pract"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jhep.2007.03.020","article-title":"Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model","volume":"47","author":"Kamada","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.23046","article-title":"Adipokines in liver diseases","volume":"50","author":"Marra","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1097\/MCG.0b013e3181962de8","article-title":"Visceral Obesity and Hypoadiponectinemia are Significant Determinants of Hepatic Dysfunction: An Epidemiologic Study of 3827 Japanese Subjects","volume":"43","author":"Kamada","year":"2009","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1381\/096089206778392149","article-title":"Gene expression of leptin, resistin, and adiponectin in the white adipose tissue of obese patients with non-alcoholic fatty liver disease and insulin resistance","volume":"16","author":"Baranova","year":"2006","journal-title":"Obes Surg"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ajcn\/87.2.295","article-title":"Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals","volume":"87","author":"Koska","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1210\/jc.2007-0187","article-title":"Postprandial lipemia associates with liver fat content","volume":"92","author":"Matikainen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/hep.20896","article-title":"Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease","volume":"42","author":"Musso","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0929-6646(09)60079-6","article-title":"The clinical implications of blood adiponectin in cardiometabolic disorders","volume":"108","author":"Chang","year":"2009","journal-title":"J Formos Med Assoc"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1136\/gut.2003.027086","article-title":"Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance","volume":"53","author":"Donati","year":"2004","journal-title":"Gut"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1097\/HJH.0b013e32830dfe4b","article-title":"Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients","volume":"26","author":"Fallo","year":"2008","journal-title":"J Hypertens"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/HJH.0b013e328317a7bb","article-title":"High-normal blood pressure is associated with a cluster of cardiovascular and metabolic risk factors: a population-based study","volume":"27","author":"Bo","year":"2009","journal-title":"J Hypertens"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.numecd.2008.12.007","article-title":"Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension","volume":"19","author":"Fallo","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/sj.jhh.1002148","article-title":"Hypertension and fatty liver: guilty by association?","volume":"21","author":"Brookes","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.metabol.2004.11.008","article-title":"Exercise training is not associated with improved levels of C-reactive protein or adiponectin","volume":"54","author":"Marcell","year":"2005","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.metabol.2007.03.009","article-title":"In the absence of weight loss, exercise training does not improve adipokines or oxidative stress in overweight children","volume":"56","author":"Kelly","year":"2007","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1001\/jama.289.14.1799","article-title":"Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial","volume":"289","author":"Esposito","year":"2003","journal-title":"JAMA"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3945\/ajcn.2008.26371","article-title":"Association of 1-y changes in diet pattern with cardiovascular disease risk factors and adipokines: results from the 1-y randomized Oslo Diet and Exercise Study","volume":"89","author":"Jacobs","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/HJR.0b013e3282efaf50","article-title":"The anti-inflammatory effects of exercise training in patients with type 2 diabetes mellitus","volume":"14","author":"Kadoglou","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.metabol.2005.01.033","article-title":"Effects of diet and\/or exercise on the adipocytokine and inflammatory cytokine levels of postmenopausal women with type 2 diabetes","volume":"54","author":"Giannopoulou","year":"2005","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hep.22575","article-title":"Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial","volume":"49","author":"Harrison","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/jama.295.7.761","article-title":"Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial","volume":"295","author":"Pi-Sunyer","year":"2006","journal-title":"JAMA"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despres","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/S0140-6736(06)69571-8","article-title":"Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study","volume":"368","author":"Scheen","year":"2006","journal-title":"Lancet"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1464-5491.2005.01569.x","article-title":"Sibutramine improves insulin sensitivity without alteration of serum adiponectin in obese subjects with Type 2 diabetes","volume":"22","author":"Hung","year":"2005","journal-title":"Diabet Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jnutbio.2007.05.007","article-title":"Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss","volume":"19","author":"Jung","year":"2008","journal-title":"J Nutr Biochem"},{"issue":"Suppl. 1","key":"10.1111\/j.1463-1326.2009.01176.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.diabres.2003.12.008","article-title":"Sibutramine improves fat distribution and insulin resistance, and increases serum adiponectin levels in Korean obese nondiabetic premenopausal women","volume":"66","author":"Kim","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.metabol.2003.11.022","article-title":"Modest weight loss and reduction in waist circumference after medical treatment are associated with favorable changes in serum adipocytokines","volume":"53","author":"Valsamakis","year":"2004","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s11695-008-9678-5","article-title":"GLP-1 and adiponectin: effect of weight loss after dietary restriction and gastric bypass in morbidly obese patients with normal and abnormal glucose metabolism","volume":"19","author":"De Carvalho","year":"2009","journal-title":"Obes Surg"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.1210\/jc.2007-1370","article-title":"Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin","volume":"93","author":"Garcia de la","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2337\/db06-1161","article-title":"Increases in adiponectin predict improved liver, but not peripheral, insulin sensitivity in severely obese women during weight loss","volume":"56","author":"Lin","year":"2007","journal-title":"Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB122|cit122","first-page":"1266","article-title":"Increase in high molecular weight adiponectin by bariatric surgery-induced weight loss","volume":"10","author":"Linscheid","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.soard.2008.08.013","article-title":"Response of adiponectin and its receptors to changes in metabolic state after gastric bypass surgery: dissociation between adipose tissue expression and circulating levels","volume":"5","author":"Savu","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB125|cit125","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2006.05.005","article-title":"Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement","volume":"4","author":"Lutchman","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/diabetes.53.8.2169","article-title":"Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes","volume":"53","author":"Tiikkainen","year":"2004","journal-title":"Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2265.2006.02658.x","article-title":"Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus","volume":"65","author":"Sharma","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1365-2265.2006.02723.x","article-title":"Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus","volume":"66","author":"Kim","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.metabol.2007.03.018","article-title":"Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus","volume":"56","author":"Hsieh","year":"2007","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.metabol.2008.07.030","article-title":"Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia","volume":"57","author":"Hyogo","year":"2008","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.atherosclerosis.2006.08.028","article-title":"Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia","volume":"193","author":"Nakamura","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/MCG.0b013e31815591aa","article-title":"Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis","volume":"42","author":"Tanaka","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB134|cit134","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1210\/jc.2005-1231","article-title":"Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes","volume":"91","author":"Hermann","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB135|cit135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1440-1797.2007.00764.x","article-title":"Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome","volume":"12","author":"Yilmaz","year":"2007","journal-title":"Nephrology (Carlton)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB136|cit136","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.HYP.0000078490.59735.6E","article-title":"Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension","volume":"42","author":"Furuhashi","year":"2003","journal-title":"Hypertension"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB137|cit137","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1365-2710.2007.00820.x","article-title":"Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone","volume":"32","author":"Derosa","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB138|cit138","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.metabol.2006.07.025","article-title":"The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy","volume":"55","author":"Matsumoto","year":"2006","journal-title":"Metabolism"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB139|cit139","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1152\/ajpendo.00133.2006","article-title":"Effects of insulin therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes","volume":"292","author":"Juurinen","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB140|cit140","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.physbeh.2007.03.004","article-title":"Effects of very low calorie diet induced body weight loss with or without human pegylated recombinant leptin treatment on changes in ghrelin and adiponectin concentrations","volume":"91","author":"Lejeune","year":"2007","journal-title":"Physiol Behav"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB141|cit141","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ghir.2006.10.001","article-title":"The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects","volume":"17","author":"Albert","year":"2007","journal-title":"Growth Horm IGF Res"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB142|cit142","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.2337\/diabetes.54.8.2390","article-title":"Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial","volume":"54","author":"Wynne","year":"2005","journal-title":"Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB143|cit143","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1097\/HJH.0b013e328311cf37","article-title":"Central sympatholytic therapy has anti-inflammatory properties in hypertensive postmenopausal women","volume":"26","author":"Poyhonen-Alho","year":"2008","journal-title":"J Hypertens"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB144|cit144","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.amjhyper.2005.05.026","article-title":"Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension","volume":"18","author":"Nowak","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB145|cit145","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/j.1478-3231.2009.02037.x","article-title":"Effects of ursodeoxycholic acid in combination with vitamin E on adipokines and apoptosis in patients with nonalcoholic steatohepatitis","volume":"29","author":"Balmer","year":"2009","journal-title":"Liver Int"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB146|cit146","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2008.06.047","article-title":"Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis","volume":"135","author":"Aithal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB147|cit147","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/MOG.0b013e3283294a18","article-title":"Recent advances in nonalcoholic fatty liver disease","volume":"25","author":"Cheung","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB148|cit148","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.22603","article-title":"Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management","volume":"49","author":"Vuppalanchi","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB149|cit149","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0028-1091984","article-title":"Current and emerging therapies in nonalcoholic fatty liver disease","volume":"28","author":"Kashi","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB150|cit150","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1478-3231.2007.01574.x","article-title":"Clinicopathological improvement of non-alcoholic steatohepatitis associated with weight loss during a 14-year follow-up period","volume":"27","author":"Nishide","year":"2007","journal-title":"Liver Int"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB151|cit151","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2265.2004.02101.x","article-title":"Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers","volume":"61","author":"Wolfe","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB152|cit152","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/ENDO:26:1:065","article-title":"Lack of increase of serum adiponectin concentrations with a moderate weight loss during six months on a high-caloric diet in military service among a young male Finnish population","volume":"26","author":"Mousavinasab","year":"2005","journal-title":"Endocrine"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB153|cit153","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB154|cit154","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1053\/j.gastro.2008.02.077","article-title":"Diagnosis and therapy of nonalcoholic steatohepatitis","volume":"134","author":"Torres","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB155|cit155","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1172\/JCI25076","article-title":"Food for thought: endocannabinoid modulation of lipogenesis","volume":"115","author":"Lichtman","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB156|cit156","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/hep.21641","article-title":"Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa\/fa rats","volume":"46","author":"Gary-Bobo","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB157|cit157","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2353\/ajpath.2008.070720","article-title":"Prevention of hepatic fibrosis in a murine model of metabolic syndrome with nonalcoholic steatohepatitis","volume":"173","author":"DeLeve","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB158|cit158","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/sj.bjp.0707511","article-title":"CB2 receptors as new therapeutic targets for liver diseases","volume":"153","author":"Lotersztajn","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB159|cit159","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1185\/030079905X38132","article-title":"A review of the metabolic effects of sibutramine","volume":"21","author":"Filippatos","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB160|cit160","first-page":"189","article-title":"The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis","volume":"12","author":"Sabuncu","year":"2003","journal-title":"Rom J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB161|cit161","first-page":"364","article-title":"Nonalcoholic fatty liver disease in severely obese individuals: the influence of bariatric surgery","volume":"7","author":"De Andrade","year":"2008","journal-title":"Ann Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB162|cit162","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","article-title":"Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"6","author":"Mummadi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB163|cit163","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1074\/jbc.M311113200","article-title":"Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity","volume":"279","author":"Pajvani","year":"2004","journal-title":"J Biol Chem"},{"issue":"Suppl. 1","key":"10.1111\/j.1463-1326.2009.01176.x-BIB164|cit164","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2337\/diabetes.53.2007.S43","article-title":"The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity","volume":"53","author":"Ferre","year":"2004","journal-title":"Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB165|cit165","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1074\/jbc.M505311200","article-title":"Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists","volume":"281","author":"Nawrocki","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB166|cit166","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1542-3565(04)00457-4","article-title":"A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis","volume":"2","author":"Sanyal","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB167|cit167","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/hep.21661","article-title":"The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis","volume":"46","author":"Lutchman","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB168|cit168","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14740330802597821","article-title":"How safe is the use of thiazolidinediones in clinical practice?","volume":"8","author":"Rizos","year":"2009","journal-title":"Expert Opin Drug Saf"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB169|cit169","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/79697","article-title":"Metformin reverses fatty liver disease in obese, leptin-deficient mice","volume":"6","author":"Lin","year":"2000","journal-title":"Nat Med"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB170|cit170","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1572-0241.2005.41583.x","article-title":"A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease","volume":"100","author":"Bugianesi","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB171|cit171","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(01)06042-1","article-title":"Metformin in non-alcoholic steatohepatitis","volume":"358","author":"Marchesini","year":"2001","journal-title":"Lancet"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB172|cit172","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2036.2004.02025.x","article-title":"Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial","volume":"20","author":"Nair","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB173|cit173","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2036.2004.01888.x","article-title":"Metformin in the treatment of patients with non-alcoholic steatohepatitis","volume":"19","author":"Uygun","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB174|cit174","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1399-5448.2008.00450.x","article-title":"Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents","volume":"10","author":"Nadeau","year":"2009","journal-title":"Pediatr Diabetes"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB175|cit175","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3132\/dvdr.2008.027","article-title":"Metformin therapy and clinical uses.","volume":"5","author":"Scarpello","year":"2008","journal-title":"Diab Vasc Dis Res"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB176|cit176","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1365-2036.2006.02926.x","article-title":"A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients","volume":"23","author":"Gomez-Dominguez","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB177|cit177","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2007.02.013","article-title":"Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study","volume":"47","author":"Ekstedt","year":"2007","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB178|cit178","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1742-1241.2007.01666.x","article-title":"Weight loss, dietary advice and statin therapy in non-alcoholic fatty liver disease: a retrospective study","volume":"62","author":"Riley","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB179|cit179","first-page":"102","article-title":"PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes","volume":"23","author":"Seo","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB180|cit180","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S0168-8278(99)80243-8","article-title":"A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis","volume":"31","author":"Basaranoglu","year":"1999","journal-title":"J Hepatol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB181|cit181","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1152\/ajpendo.00340.2006","article-title":"Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes","volume":"292","author":"Nakano","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB182|cit182","doi-asserted-by":"crossref","first-page":"6395","DOI":"10.3748\/wjg.14.6395","article-title":"Effects of n-3 polyunsaturated fatty acids from seal oils on nonalcoholic fatty liver disease associated with hyperlipidemia","volume":"14","author":"Zhu","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB183|cit183","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/hep.20420","article-title":"Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis","volume":"40","author":"Yokohama","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB184|cit184","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3748\/wjg.v12.i2.322","article-title":"Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis","volume":"12","author":"Yokohama","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB185|cit185","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.atherosclerosis.2009.01.026","article-title":"Losartan reduces liver expression of plasminogen activator inhibitor-1 (PAI-1) in a high fat-induced rat nonalcoholic fatty liver disease model","volume":"206","author":"Rosselli","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB186|cit186","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/HYPERTENSIONAHA.108.112292","article-title":"Olmesartan prevents cardiovascular injury and hepatic steatosis in obesity and diabetes, accompanied by apoptosis signal regulating kinase-1 inhibition","volume":"52","author":"Yamamoto","year":"2008","journal-title":"Hypertension"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB187|cit187","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1440-1681.2008.05129.x","article-title":"Angiotensin converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumor necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes","volume":"36","author":"Zhang","year":"2009","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB188|cit188","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1055\/s-2008-1027411","article-title":"Adalimumab could suppress the activity of non alcoholic steatohepatitis (NASH)","volume":"46","author":"Schramm","year":"2008","journal-title":"Z Gastroenterol"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB189|cit189","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/ard.2005.040857","article-title":"No change of serum levels of leptin and adiponectin during anti-tumour necrosis factor antibody treatment with adalimumab in patients with rheumatoid arthritis","volume":"65","author":"Harle","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB190|cit190","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.mehy.2008.12.019","article-title":"Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways","volume":"72","author":"Polyzos","year":"2009","journal-title":"Med Hypotheses"},{"issue":"Suppl. 7","key":"10.1111\/j.1463-1326.2009.01176.x-BIB191|cit191","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1038\/ijo.2008.235","article-title":"Gastrointestinal satiety signals","volume":"32","author":"Chaudhri","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB192|cit192","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/MPG.0b013e31818e04d1","article-title":"Pharmacological interventions for nonalcoholic fatty liver disease in adults and in children: a systematic review","volume":"48","author":"Socha","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1111\/j.1463-1326.2009.01176.x-BIB193|cit193","author":"Angelico","first-page":"CD005166","year":"2007","article-title":"Drugs improving insulin resistance for non-alcoholic fatty liver disease and\/or non-alcoholic steatohepatitis","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Diabetes, Obesity and Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1463-1326.2009.01176.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T17:36:02Z","timestamp":1558632962000},"score":1.0,"issued":{"date-parts":[[2010,3,30]]},"references-count":193,"journal-issue":{"issue":"5"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1463-1326.2009.01176.x","relation":{"cites":[]},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T06:13:04Z","timestamp":1574403184662},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T00:00:00Z","timestamp":1262649600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Surg"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1007\/s00268-009-0362-2","type":"journal-article","created":{"date-parts":[[2010,1,4]],"date-time":"2010-01-04T16:21:18Z","timestamp":1262622078000},"page":"844-851","source":"Crossref","is-referenced-by-count":20,"title":["A Systematic Review of Cases Reporting Needle Tract Seeding Following Thyroid Fine Needle Biopsy"],"prefix":"10.1007","volume":"34","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,1,5]]},"reference":[{"key":"362_CR1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","volume":"154","author":"F Pacini","year":"2006","unstructured":"Pacini F, Schlumberger M, Dralle H et al (2006) European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154:787\u2013803","journal-title":"Eur J Endocrinol"},{"key":"362_CR2","first-page":"63","volume":"12","author":"AACE\/AME Task Force on Thyroid Nodules","year":"2006","unstructured":"AACE\/AME Task Force on Thyroid Nodules (2006) American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules. Endocr Pract 12:63\u2013102","journal-title":"Endocr Pract"},{"key":"362_CR3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/thy.2006.16.109","volume":"16","author":"DS Cooper","year":"2006","unstructured":"Cooper DS, Doherty GM, Haugen BR et al (2006) Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 16:109\u2013142","journal-title":"Thyroid"},{"key":"362_CR4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-2008-1058082","volume":"116","author":"SA Polyzos","year":"2008","unstructured":"Polyzos SA, Kita M, Goulis DG et al (2008) Epidemiologic analysis of thyroid fine needle aspiration biopsies over a period of 18\u00a0years (1987\u20132004). Exp Clin Endocrinol Diabetes 116:496\u2013500","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"362_CR5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-2008-1080922","volume":"117","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Kita M, Efstathiadou Z et al (2009) The use of demographic, ultrasonographic and scintigraphic data in the diagnostic approach of thyroid nodules. Exp Clin Endocrinol Diabetes 117:159\u2013164","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"362_CR6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0002-9343(82)90731-8","volume":"73","author":"B Hamberger","year":"1982","unstructured":"Hamberger B, Gharib H, Melton LJ III et al (1982) Fine-needle aspiration biopsy of thyroid nodules. Impact on thyroid practice and cost of care. Am J Med 73:381\u2013384","journal-title":"Am J Med"},{"key":"362_CR7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.14310\/horm.2002.111107","volume":"6","author":"SA Polyzos","year":"2007","unstructured":"Polyzos SA, Kita M, Avramidis A (2007) Thyroid nodules\u2014stepwise diagnosis and management. Hormones (Athens) 6:101\u2013119","journal-title":"Hormones (Athens)"},{"key":"362_CR8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1365-2265.2009.03522.x","volume":"71","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Anastasilakis AD (2009) Clinical complications following thyroid fie needle biopsy: a systematic review. Clin Endocrinol (Oxf) 71:157\u2013165","journal-title":"Clin Endocrinol (Oxf)"},{"key":"362_CR9","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/dc.21055","volume":"37","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Patsiaoura K, Zachou K (2009) Histological alterations following thyroid fine needle biopsy: a systematic review. Diagn Cytopathol 37:455\u2013465","journal-title":"Diagn Cytopathol"},{"key":"362_CR10","unstructured":"Polyzos SA, Anastasilakis AD (2009) Alterations in serum thyroid-related constituents following thyroid fine needle biopsy: a systematic review. Thyroid (epub)","DOI":"10.1111\/j.1365-2265.2009.03522.x","doi-asserted-by":"crossref"},{"key":"362_CR11","first-page":"543","volume":"17","author":"RP Gobien","year":"1979","unstructured":"Gobien RP (1979) Aspiration biopsy of the solitary thyroid nodule. Radiol Clin North Am 17:543\u2013554","journal-title":"Radiol Clin North Am"},{"key":"362_CR12","first-page":"801","volume":"34","author":"MS Hales","year":"1990","unstructured":"Hales MS, Hsu FS (1990) Needle tract implantation of papillary carcinoma of the thyroid following aspiration biopsy. Acta Cytol 34:801\u2013804","journal-title":"Acta Cytol"},{"key":"362_CR13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/1097-0142(19840701)54:1<73::AID-CNCR2820540116>3.0.CO;2-2","volume":"54","author":"O Eriksson","year":"1984","unstructured":"Eriksson O, Hagmar B, Ryd W (1984) Effects of fine-needle aspiration and other biopsy procedures on tumor dissemination in mice. Cancer 54:73\u201378","journal-title":"Cancer"},{"key":"362_CR14","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","volume":"295","author":"L Davies","year":"2006","unstructured":"Davies L, Welch HG (2006) Increasing incidence of thyroid cancer in the United States, 1973\u20132002. JAMA 295:2164\u20132167","journal-title":"JAMA"},{"key":"362_CR15","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.beem.2008.09.019","volume":"22","author":"DS Dean","year":"2008","unstructured":"Dean DS, Gharib H (2008) Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 22:901\u2013911","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"362_CR16","first-page":"904","volume":"5","author":"NL Wilczynski","year":"2002","unstructured":"Wilczynski NL, Haynes RB (2002) Robustness of empirical search strategies for clinical content in Medline. Proc AMIA Symp 5:904\u2013908","journal-title":"Proc AMIA Symp"},{"key":"362_CR17","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4158\/EP.10.4.353","volume":"10","author":"AACE Ad Hoc Task Force","year":"2004","unstructured":"AACE Ad Hoc Task Force (2004) American Association of Clinical Endocrinologists protocol for standardized production of clinical practice guidelines. Endocr Pract 10:353\u2013361","journal-title":"Endocr Pract"},{"key":"362_CR18","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1007\/s00268-005-0086-x","volume":"29","author":"Y Ito","year":"2005","unstructured":"Ito Y, Tomoda C, Uruno T et al (2005) Needle tract implantation of papillary thyroid carcinoma after fine-needle aspiration biopsy. World J Surg 29:1544\u20131549","journal-title":"World J Surg"},{"key":"362_CR19","first-page":"161","volume":"102","author":"G Crile Jr","year":"1956","unstructured":"Crile G Jr (1956) The danger of surgical dissemination of papillary carcinoma of the thyroid. Surg Gynecol Obstet 102:161\u2013165","journal-title":"Surg Gynecol Obstet"},{"key":"362_CR20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/BF02393534","volume":"4","author":"MA Block","year":"1980","unstructured":"Block MA, Miller JM, Kini SR (1980) The potential impact of needle biopsy on surgery for thyroid nodules. World J Surg 4:737\u2013741","journal-title":"World J Surg"},{"key":"362_CR21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1159\/000326884","volume":"46","author":"JK Karwowski","year":"2002","unstructured":"Karwowski JK, Nowels KW, McDougall IR et al (2002) Needle track seeding of papillary thyroid carcinoma from fine needle aspiration biopsy. Acta Cytol 46:591\u2013595","journal-title":"Acta Cytol"},{"key":"362_CR22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0385-8146(01)00093-1","volume":"28","author":"S Shinohara","year":"2001","unstructured":"Shinohara S, Yamamoto E, Tanabe M et al (2001) Implantation metastasis of head and neck cancer after fine needle aspiration biopsy. Auris Nasus Larynx 28:377\u2013380","journal-title":"Auris Nasus Larynx"},{"key":"362_CR23","first-page":"169","volume":"15","author":"D Tamiolakis","year":"2006","unstructured":"Tamiolakis D, Antoniou C, Venizelos J et al (2006) Papillary thyroid carcinoma metastasis most probably due to fine needle aspiration biopsy. A case report. Acta Dermatovenerol Alp Panonica Adriat 15:169\u2013172","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"362_CR24","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1089\/thy.2006.16.1059","volume":"16","author":"Y Ito","year":"2006","unstructured":"Ito Y, Asahi S, Matsuzuka F et al (2006) Needle tract implantation of follicular neoplasm after fine-needle aspiration biopsy: report of a case. Thyroid 16:1059\u20131062","journal-title":"Thyroid"},{"key":"362_CR25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/dc.2840100212","volume":"10","author":"C Panunzi","year":"1994","unstructured":"Panunzi C, Paliotta DS, Papini E et al (1994) Cutaneous seeding of a follicular thyroid cancer after fine-needle aspiration biopsy? Diagn Cytopathol 10:156\u2013158","journal-title":"Diagn Cytopathol"},{"key":"362_CR26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00595-006-3331-5","volume":"37","author":"N Uchida","year":"2007","unstructured":"Uchida N, Suda T, Inoue T et al (2007) Needle track dissemination of follicular thyroid carcinoma following fine-needle aspiration biopsy: report of a case. Surg Today 37:34\u201337","journal-title":"Surg Today"},{"key":"362_CR27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1017\/S0022215106003264","volume":"121","author":"E Abelardo","year":"2007","unstructured":"Abelardo E, Jaramillo M, Sheffield E et al (2007) Anaplastic thyroid carcinoma implantation after fine needle aspiration cytology. J Laryngol Otol 121:268\u2013270","journal-title":"J Laryngol Otol"},{"key":"362_CR28","first-page":"365","volume":"143","author":"C Wang","year":"1976","unstructured":"Wang C, Vickery AL Jr, Maloof F (1976) Needle biopsy of the thyroid. Surg Gynecol Obstet 143:365\u2013368","journal-title":"Surg Gynecol Obstet"},{"key":"362_CR29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1196\/annals.1414.010","volume":"1138","author":"A Shaha","year":"2008","unstructured":"Shaha A (2008) Selective surgical management of well-differentiated thyroid cancer. Ann N Y Acad Sci 1138:58\u201364","journal-title":"Ann N Y Acad Sci"},{"key":"362_CR30","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1479-666X(05)80091-5","volume":"3","author":"SA Rizvi","year":"2005","unstructured":"Rizvi SA, Husain M, Khan S et al (2005) A comparative study of fine needle aspiration cytology versus non-aspiration technique in thyroid lesions. Surgeon 3:273\u2013276","journal-title":"Surgeon"},{"key":"362_CR31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/dc.20829","volume":"36","author":"MB Pitman","year":"2008","unstructured":"Pitman MB, Abele J, Ali SZ et al (2008) Techniques for thyroid FNA: a synopsis of the National Cancer Institute Thyroid Fine-Needle Aspiration State of the Science Conference. Diagn Cytopathol 36:407\u2013424","journal-title":"Diagn Cytopathol"},{"key":"362_CR32","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1081\/CNV-200027160","volume":"22","author":"M Wu","year":"2004","unstructured":"Wu M, Burstein DE (2004) Fine needle aspiration. Cancer Invest 22:620\u2013628","journal-title":"Cancer Invest"},{"key":"362_CR33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-2265.1988.tb03696.x","volume":"29","author":"TC Chang","year":"1988","unstructured":"Chang TC, Kuo SH, Liaw KY et al (1988) Cell kinetics, DNA content and TSH receptor\u2013adenylate cyclase system in differentiated thyroid cancer. Clin Endocrinol (Oxf) 29:477\u2013484","journal-title":"Clin Endocrinol (Oxf)"},{"key":"362_CR34","first-page":"4318","volume":"81","author":"P Pujol","year":"1996","unstructured":"Pujol P, Daures JP, Nsakala N et al (1996) Degree of thyrotropin suppression as a prognostic determinant in differentiated thyroid cancer. J Clin Endocrinol Metab 81:4318\u20134323","journal-title":"J Clin Endocrinol Metab"},{"key":"362_CR35","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00432-008-0373-7","volume":"134","author":"SA Polyzos","year":"2008","unstructured":"Polyzos SA, Kita M, Efstathiadou Z et al (2008) Serum thyrotropin concentration as a biochemical predictor of thyroid malignancy in patients presenting with thyroid nodules. J Cancer Res Clin Oncol 134:953\u2013960","journal-title":"J Cancer Res Clin Oncol"},{"key":"362_CR36","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1210\/jc.2006-0527","volume":"91","author":"K Boelaert","year":"2006","unstructured":"Boelaert K, Horacek J, Holder RL et al (2006) Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab 91:4295\u20134301","journal-title":"J Clin Endocrinol Metab"},{"key":"362_CR37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jc.2007-2215","volume":"93","author":"MR Haymart","year":"2008","unstructured":"Haymart MR, Repplinger DJ, Leverson GE et al (2008) Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 93:809\u2013814","journal-title":"J Clin Endocrinol Metab"},{"key":"362_CR38","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/jcp.2003.012922","volume":"57","author":"S Alwaheeb","year":"2004","unstructured":"Alwaheeb S, Ghazarian D, Boerner SL et al (2004) Cutaneous manifestations of thyroid cancer: a report of four cases and review of the literature. J Clin Pathol 57:435\u2013438","journal-title":"J Clin Pathol"},{"key":"362_CR39","first-page":"936","volume":"33","author":"F Roussel","year":"1989","unstructured":"Roussel F, Dalion J, Benozio M (1989) The risk of tumoral seeding in needle biopsies. Acta Cytol 33:936\u2013939","journal-title":"Acta Cytol"},{"key":"362_CR40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1148\/radiology.178.1.1984314","volume":"178","author":"EH Smith","year":"1991","unstructured":"Smith EH (1991) Complications of percutaneous abdominal fine-needle biopsy. Review. Radiology 178:253\u2013258","journal-title":"Radiology"},{"key":"362_CR41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00268-004-6865-y","volume":"28","author":"C Kosugi","year":"2004","unstructured":"Kosugi C, Furuse J, Ishii H et al (2004) Needle tract implantation of hepatocellular carcinoma and pancreatic carcinoma after ultrasound-guided percutaneous puncture: clinical and pathologic characteristics and the treatment of needle tract implantation. World J Surg 28:29\u201332","journal-title":"World J Surg"},{"key":"362_CR42","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ctrv.2007.04.001","volume":"33","author":"R Stigliano","year":"2007","unstructured":"Stigliano R, Marelli L, Yu D et al (2007) Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev 33:437\u2013447","journal-title":"Cancer Treat Rev"},{"key":"362_CR43","first-page":"1823","volume":"12","author":"C Boutin","year":"1983","unstructured":"Boutin C, Irisson M, Rathelot P et al (1983) Parietal extension of diffuse malignant pleural mesothelioma after biopsy. Prevention by local radiotherapy. Presse Med 12:1823\u20131823","journal-title":"Presse Med"},{"key":"362_CR44","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.urology.2005.04.005","volume":"66","author":"H Vaghefi","year":"2005","unstructured":"Vaghefi H, Magi-Galluzzi C, Klein EA (2005) Local recurrence of prostate cancer in rectal submucosa after transrectal needle biopsy and radical prostatectomy. Urology 66:881\u2013881","journal-title":"Urology"},{"key":"362_CR45","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0090-4295(97)00487-1","volume":"51","author":"JW Moul","year":"1998","unstructured":"Moul JW, Bauer JJ, Srivastava S et al (1998) Perineal seeding of prostate cancer as the only evidence of clinical recurrence 14\u00a0years after needle biopsy and radical prostatectomy: molecular correlation. Urology 51:158\u2013160","journal-title":"Urology"},{"key":"362_CR46","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/0090-4295(86)90340-7","volume":"27","author":"JB Emtage","year":"1986","unstructured":"Emtage JB, Perez-Marrero R (1986) Extension of carcinoma of prostate along perineal needle biopsy tract. Urology 27:548\u2013549","journal-title":"Urology"},{"key":"362_CR47","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10549-007-9685-6","volume":"110","author":"T Uematsu","year":"2008","unstructured":"Uematsu T, Kasami M (2008) Risk of needle tract seeding of breast cancer: cytological results derived from core wash material. Breast Cancer Res Treat 110:51\u201355","journal-title":"Breast Cancer Res Treat"},{"key":"362_CR48","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.ophtha.2006.05.042","volume":"113","author":"CL Shields","year":"2006","unstructured":"Shields CL, Manquez ME, Ehya H et al (2006) Fine-needle aspiration biopsy of iris tumors in 100 consecutive cases: technique and complications. Ophthalmology 113:2080\u20132086","journal-title":"Ophthalmology"},{"key":"362_CR49","first-page":"82","volume":"25","author":"E Struve-Christensen","year":"1978","unstructured":"Struve-Christensen E (1978) Iatrogenic dissemination of tumour cells. Dissemination of tumour cells along the needle track after percutaneous, transthoracic lung biopsy. Dan Med Bull 25:82\u201387","journal-title":"Dan Med Bull"},{"key":"362_CR50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1055\/s-2007-1005981","volume":"10","author":"H Weiss","year":"1989","unstructured":"Weiss H (1989) Metastases caused by fine needle puncture? Ultraschall Med 10:147\u2013151","journal-title":"Ultraschall Med"},{"key":"362_CR51","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jcp.51.3.241","volume":"51","author":"AJ Mighell","year":"1998","unstructured":"Mighell AJ, High AS (1998) Histological identification of carcinoma in 21 gauge needle tracks after fine needle aspiration biopsy of head and neck carcinoma. J Clin Pathol 51:241\u2013243","journal-title":"J Clin Pathol"},{"key":"362_CR52","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1245\/ASO.2006.08.020","volume":"13","author":"DY Greenblatt","year":"2006","unstructured":"Greenblatt DY, Woltman T, Harter J et al (2006) Fine-needle aspiration optimizes surgical management in patients with thyroid cancer. Ann Surg Oncol 13:859\u2013863","journal-title":"Ann Surg Oncol"},{"key":"362_CR53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/(SICI)1097-0339(199607)15:1<84::AID-DC18>3.0.CO;2-8","volume":"15","author":"The Papanicolaou Society of Cytopathology Task Force on Standards of Practice","year":"1996","unstructured":"The Papanicolaou Society of Cytopathology Task Force on Standards of Practice (1996) Guidelines of the Papanicolaou Society of Cytopathology for the examination of fine-needle aspiration specimens from thyroid nodules. Diagn Cytopathol 15:84\u201389","journal-title":"Diagn Cytopathol"},{"key":"362_CR54","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0272-2712(18)30434-7","volume":"13","author":"H Gharib","year":"1993","unstructured":"Gharib H, Goellner JR, Johnson DA (1993) Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11, 000 biopsies. Clin Lab Med 13:699\u2013709","journal-title":"Clin Lab Med"},{"key":"362_CR55","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.crad.2007.01.024","volume":"62","author":"B Degirmenci","year":"2007","unstructured":"Degirmenci B, Haktanir A, Albayrak R et al (2007) Sonographically guided fine-needle biopsy of thyroid nodules: the effects of nodule characteristics, sampling technique, and needle size on the adequacy of cytological material. Clin Radiol 62:798\u2013803","journal-title":"Clin Radiol"},{"key":"362_CR56","first-page":"199","volume":"46","author":"AE Hanbidge","year":"1995","unstructured":"Hanbidge AE, Arenson AM, Shaw PA et al (1995) Needle size and sample adequacy in ultrasound-guided biopsy of thyroid nodules. Can Assoc Radiol J 46:199\u2013201","journal-title":"Can Assoc Radiol J"},{"key":"362_CR57","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/105072501753211055","volume":"11","author":"V Tangpricha","year":"2001","unstructured":"Tangpricha V, Chen BJ, Swan NC et al (2001) Twenty-one-gauge needles provide more cellular samples than twenty-five-gauge needles in fine-needle aspiration biopsy of the thyroid but may not provide increased diagnostic accuracy. Thyroid 11:973\u2013976","journal-title":"Thyroid"}],"container-title":["World Journal of Surgery"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00268-009-0362-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00268-009-0362-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00268-009-0362-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T22:21:49Z","timestamp":1558736509000},"score":1.0,"issued":{"date-parts":[[2010,1,5]]},"references-count":57,"journal-issue":{"published-print":{"date-parts":[[2010,4]]},"issue":"4"},"alternative-id":["362"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00268-009-0362-2","relation":{"cites":[]},"ISSN":["0364-2313","1432-2323"],"issn-type":[{"value":"0364-2313","type":"print"},{"value":"1432-2323","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T07:03:59Z","timestamp":1574406239433},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.mehy.2009.12.028","type":"journal-article","created":{"date-parts":[[2010,1,19]],"date-time":"2010-01-19T10:57:33Z","timestamp":1263898653000},"page":"1089-1090","source":"Crossref","is-referenced-by-count":11,"title":["Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: The two sides of the same coin"],"prefix":"10.1016","volume":"74","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Stergiopoulos","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Medical Hypotheses"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709008408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987709008408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T06:58:31Z","timestamp":1558767511000},"score":1.0,"issued":{"date-parts":[[2010,6]]},"references-count":5,"journal-issue":{"published-print":{"date-parts":[[2010,6]]},"issue":"6"},"alternative-id":["S0306987709008408"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.mehy.2009.12.028","ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T11:10:24Z","timestamp":1574421024883},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jocd.2010.01.006","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T18:02:20Z","timestamp":1269972140000},"page":"190-196","source":"Crossref","is-referenced-by-count":2,"title":["Dual-Energy X-Ray Absorptiometry and Quantitative Ultrasound in Patients With Paget's Disease of Bone Before and After Treatment With Zoledronic Acid: Association With Serum Bone Markers and Dickkopf-1"],"prefix":"10.1016","volume":"13","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Ioannis","family":"Litsas","sequence":"additional","affiliation":[]},{"given":"Michail","family":"Sapranidis","sequence":"additional","affiliation":[]},{"given":"Zoe","family":"Efstathiadou","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Kita","sequence":"additional","affiliation":[]},{"given":"Georgios","family":"Arsos","sequence":"additional","affiliation":[]},{"given":"Efstratios","family":"Moralidis","sequence":"additional","affiliation":[]},{"given":"Efthimia","family":"Zafeiriadou","sequence":"additional","affiliation":[]},{"given":"Athanasios","family":"Papatheodorou","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Journal of Clinical Densitometry"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695010000077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094695010000077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T20:40:08Z","timestamp":1558989608000},"score":1.0,"issued":{"date-parts":[[2010,4]]},"references-count":29,"journal-issue":{"published-print":{"date-parts":[[2010,4]]},"issue":"2"},"alternative-id":["S1094695010000077"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.jocd.2010.01.006","ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T08:36:33Z","timestamp":1574411793851},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Gastroenterology"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1097\/mcg.0b013e3181b5ce68","type":"journal-article","created":{"date-parts":[[2010,2,17]],"date-time":"2010-02-17T07:29:26Z","timestamp":1266391766000},"page":"229-230","source":"Crossref","is-referenced-by-count":11,"title":["Nonlinear Distribution of Adiponectin in Patients With Nonalcoholic Fatty Liver Disease Limits Its Use in Linear Regression Analysis"],"prefix":"10.1097","volume":"44","author":[{"given":"Stergios Alexandros","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]}],"member":"276","container-title":["Journal of Clinical Gastroenterology"],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/jcge\/Fulltext\/10.1097\/MCG.0b013e3181b5ce68","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T17:33:14Z","timestamp":1551202394000},"score":1.0,"subtitle":[""],"issued":{"date-parts":[[2010,3]]},"references-count":11,"journal-issue":{"issue":"3"},"URL":"http:\/\/dx.doi.org\/10.1097\/mcg.0b013e3181b5ce68","ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T11:04:29Z","timestamp":1574420669219},"reference-count":13,"publisher":"Wiley","issue":"4","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1979,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1111\/j.1872-034x.2010.00632.x","type":"journal-article","created":{"date-parts":[[2010,3,29]],"date-time":"2010-03-29T16:16:21Z","timestamp":1269879381000},"page":"446-447","source":"Crossref","is-referenced-by-count":9,"title":["Adiponectin as a potential therapeutic agent for nonalcoholic steatohepatitis"],"prefix":"10.1111","volume":"40","member":"311","reference":[{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/j.1872-034X.2009.00509.x","article-title":"Adiponectin prevents progression of steatohepatitis in mice by regulating oxidative stress and Kupffer cell phenotype polarization","volume":"39","author":"Fukushima","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB2","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1872-034X.2009.00596.x","article-title":"Adiponectin as a therapeutic target of non-alcoholic steatohepatitis","volume":"39","author":"Shiota","year":"2009","journal-title":"Hepatol Res"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/90992","article-title":"The adipocyte-secreted protein Acrp30 enhances hepatic insulin action","volume":"7","author":"Berg","year":"2001","journal-title":"Nat Med"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB5","doi-asserted-by":"crossref","first-page":"19521","DOI":"10.1074\/jbc.M200601200","article-title":"Hydroxylation and glycosylation of the four conserved lysine residues in the collagenous domain of adiponectin. Potential role in the modulation of its insulin-sensitizing activity","volume":"277","author":"Wang","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB6","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI200317797","article-title":"The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB7","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/en.2004-1572","article-title":"Regulation of T cell-mediated hepatic inflammation by adiponectin and leptin","volume":"146","author":"Sennello","year":"2005","journal-title":"Endocrinology"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB8","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hep.21935","article-title":"Activation of peroxisome proliferator-activated receptor-alpha inhibits the injurious effects of adiponectin in rat steatotic liver undergoing ischemia-reperfusion","volume":"47","author":"Massip-Salcedo","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB9","author":"Polyzos","year":"2009","article-title":"The role of adiponectin in the pathogenesis and treatment of nonalcoholic fatty liver disease","journal-title":"Diabetes Obes Metab"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB10","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1478-3231.2004.0986.x","article-title":"Elevated plasma adiponectin concentrations in patients with liver cirrhosis correlate with plasma insulin levels","volume":"25","author":"Sohara","year":"2005","journal-title":"Liver Int"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB11","first-page":"725","article-title":"Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in rats","volume":"20","author":"Asada","year":"2007","journal-title":"Int J Mol Med"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"72","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1111\/j.1872-034X.2010.00632.x-BIB13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.molcel.2004.11.050","article-title":"Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptor","volume":"17","author":"Narasimhan","year":"2005","journal-title":"Mol Cell"}],"container-title":["Hepatology Research"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1872-034X.2010.00632.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,27]],"date-time":"2019-02-27T17:42:42Z","timestamp":1551289362000},"score":1.0,"issued":{"date-parts":[[2010,4]]},"references-count":13,"journal-issue":{"published-print":{"date-parts":[[2010,4]]},"issue":"4"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1872-034x.2010.00632.x","relation":{"cites":[]},"ISSN":["1386-6346","1872-034X"],"issn-type":[{"value":"1386-6346","type":"print"},{"value":"1872-034X","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T15:03:20Z","timestamp":1574435000698},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2010,6,9]],"date-time":"2010-06-09T00:00:00Z","timestamp":1276041600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00774-010-0198-8","type":"journal-article","created":{"date-parts":[[2010,6,8]],"date-time":"2010-06-08T07:00:19Z","timestamp":1275980419000},"page":"706-712","source":"Crossref","is-referenced-by-count":16,"title":["Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget\u2019s disease"],"prefix":"10.1007","volume":"28","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Ioannis","family":"Litsas","sequence":"additional","affiliation":[]},{"given":"Zoe","family":"Efstathiadou","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Kita","sequence":"additional","affiliation":[]},{"given":"Georgios","family":"Arsos","sequence":"additional","affiliation":[]},{"given":"Efstratios","family":"Moralidis","sequence":"additional","affiliation":[]},{"given":"Athanasios","family":"Papatheodorou","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2010,6,9]]},"reference":[{"key":"198_CR1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMoa013096","volume":"347","author":"MP Whyte","year":"2002","unstructured":"Whyte MP, Obrecht SE, Finnegan PM, Jones JL, Podgornik MN, McAlister WH, Mumm S (2002) Osteoprotegerin deficiency and juvenile Paget\u2019s disease. N Engl J Med 347:175\u2013184","journal-title":"N Engl J Med"},{"key":"198_CR2","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1093\/hmg\/11.18.2119","volume":"11","author":"T Cundy","year":"2002","unstructured":"Cundy T, Hegde M, Naot D, Chong B, King A, Wallace R, Mulley J, Love DR, Seidel J, Fawkner M, Banovic T, Callon KE, Grey AB, Reid IR, Middleton-Hardie CA, Cornish J (2002) A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Genet 11:2119\u20132127","journal-title":"Hum Mol Genet"},{"key":"198_CR3","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1210\/jc.2006-0479","volume":"92","author":"S Simsek","year":"2007","unstructured":"Simsek S, Basoski NM, Bravenboer N, Zhang X, Mumm S, Whyte MP, Netelenbos JC (2007) Sporadic hyperphosphatasia syndrome featuring periostitis and accelerated skeletal turnover without receptor activator of nuclear factor-kappaB, osteoprotegerin, or sequestosome-1 gene defects. J Clin Endocrinol Metab 92:1897\u20131901","journal-title":"J Clin Endocrinol Metab"},{"key":"198_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.berh.2007.11.005","volume":"22","author":"SH Ralston","year":"2008","unstructured":"Ralston SH (2008) Juvenile Paget\u2019s disease, familial expansile osteolysis and other genetic osteolytic disorders. Best Pract Res Clin Rheumatol 22:101\u2013111","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"198_CR5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jbmr.5650090519","volume":"9","author":"F Singer","year":"1994","unstructured":"Singer F, Siris E, Shane E, Dempster D, Lindsay R, Parisien M (1994) Hereditary hyperphosphatasia: 20\u00a0year follow-up and response to disodium etidronate. J Bone Miner Res 9:733\u2013738","journal-title":"J Bone Miner Res"},{"key":"198_CR6","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa050893","volume":"353","author":"T Cundy","year":"2005","unstructured":"Cundy T, Davidson J, Rutland MD, Stewart C, DePaoli AM (2005) Recombinant osteoprotegerin for juvenile Paget\u2019s disease. N Engl J Med 353:918\u2013923","journal-title":"N Engl J Med"},{"key":"198_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1259\/0007-1285-47-553-9","volume":"47","author":"FH Doyle","year":"1974","unstructured":"Doyle FH, Woodhouse NJ, Glen AC, Joplin GF, MacIntyre I (1974) Healing of the bones in juvenile Paget\u2019s disease treated by human calcitonin. Br J Radiol 47:9\u201315","journal-title":"Br J Radiol"},{"key":"198_CR8","first-page":"642","volume":"19","author":"A Spindler","year":"1992","unstructured":"Spindler A, Berman A, Mautalen C, Ubios J, Santini AE (1992) Chronic idiopathic hyperphosphatasia. Report of a case treated with pamidronate and a review of the literature. J Rheumatol 19:642\u2013645","journal-title":"J Rheumatol"},{"key":"198_CR9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bone.2004.03.013","volume":"35","author":"C Tau","year":"2004","unstructured":"Tau C, Mautalen C, Casco C, Alvarez V, Rubinstein M (2004) Chronic idiopathic hyperphosphatasia: normalization of bone turnover with cyclical intravenous pamidronate therapy. Bone (NY) 35:210\u2013216","journal-title":"Bone (NY)"},{"key":"198_CR10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1359\/jbmr.040127","volume":"19","author":"T Cundy","year":"2004","unstructured":"Cundy T, Wheadon L, King A (2004) Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy. J Bone Miner Res 19:703\u2013711","journal-title":"J Bone Miner Res"},{"key":"198_CR11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1515\/JPEM.2000.13.2.217","volume":"13","author":"E Demir","year":"2000","unstructured":"Demir E, Bereket A, Ozkan B, Topcu M (2000) Effect of alendronate treatment on the clinical picture and bone turnover markers in chronic idiopathic hyperphosphatasia. J Pediatr Endocrinol Metab 13:217\u2013221","journal-title":"J Pediatr Endocrinol Metab"},{"key":"198_CR12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","volume":"38","author":"GH Nancollas","year":"2006","unstructured":"Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RG, Ebetino FH (2006) Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone (NY) 38:617\u2013627","journal-title":"Bone (NY)"},{"key":"198_CR13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1586\/eem.09.35","volume":"4","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Anastasilakis AD, Terpos E (2009) Paget\u2019s disease of bone: emphasis on treatment with zoledronic acid. Expert Rev Endocrinol Metabolism 4:424\u2013434","journal-title":"Expert Rev Endocrinol Metabolism"},{"key":"198_CR14","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa044241","volume":"353","author":"IR Reid","year":"2005","unstructured":"Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget\u2019s disease. N Engl J Med 353:898\u2013908","journal-title":"N Engl J Med"},{"key":"198_CR15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.14310\/horm.2002.1226","volume":"8","author":"PD Papapetrou","year":"2009","unstructured":"Papapetrou PD (2009) Bisphosphonate-associated adverse events. Hormones (Athens) 8:96\u2013110","journal-title":"Hormones (Athens)"},{"key":"198_CR16","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1359\/jbmr.2001.16.9.1719","volume":"16","author":"BG Stuckey","year":"2001","unstructured":"Stuckey BG, Lim EM, Kent GN, Ward LC, Gutteridge DH (2001) Bisphosphonate therapy for Paget\u2019s disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission. J Bone Miner Res 16:1719\u20131723","journal-title":"J Bone Miner Res"},{"key":"198_CR17","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.bone.2006.04.032","volume":"39","author":"HE Whitson","year":"2006","unstructured":"Whitson HE, Lobaugh B, Lyles KW (2006) Severe hypocalcemia following bisphosphonate treatment in a patient with Paget\u2019s disease of bone. Bone (NY) 39:954\u2013958","journal-title":"Bone (NY)"},{"key":"198_CR18","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00774-008-0852-6","volume":"26","author":"A Avramidis","year":"2008","unstructured":"Avramidis A, Polyzos SA, Moralidis E, Arsos G, Efstathiadou Z, Karakatsanis K, Grollios G, Kita M (2008) Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget\u2019s disease of bone. J Bone Miner Metab 26:635\u2013641","journal-title":"J Bone Miner Metab"},{"key":"198_CR19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/jbmr.5650110206","volume":"11","author":"SA Khan","year":"1996","unstructured":"Khan SA, McCloskey EV, Eyres KS, Nakatsuka K, Sirtori P, Orgee J, Coombes G, Kanis JA (1996) Comparison of three intravenous regimens of clodronate in Paget disease of bone. J Bone Miner Res 11:178\u2013182","journal-title":"J Bone Miner Res"},{"key":"198_CR20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00198-008-0629-8","volume":"19","author":"JP Devogelaer","year":"2008","unstructured":"Devogelaer JP, Bergmann P, Body JJ, Boutsen Y, Goemaere S, Kaufman JM, Reginster JY, Rozenberg S, Boonen S (2008) Management of patients with Paget\u2019s disease: a consensus document of the Belgian Bone Club. Osteoporos Int 19:1109\u20131117","journal-title":"Osteoporos Int"},{"key":"198_CR21","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","volume":"86","author":"DB Kimmel","year":"2007","unstructured":"Kimmel DB (2007) Mechanism of action, pharmacokinetic and pharmacodynamic profile, and clinical applications of nitrogen-containing bisphosphonates. J Dent Res 86:1022\u20131033","journal-title":"J Dent Res"},{"key":"198_CR22","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/07315724.2003.10719287","volume":"22","author":"RP Heaney","year":"2003","unstructured":"Heaney RP, Dowell MS, Hale CA, Bendich A (2003) Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 22:142\u2013146","journal-title":"J Am Coll Nutr"},{"key":"198_CR23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S8756-3282(98)00163-X","volume":"24","author":"GO Stewart","year":"1999","unstructured":"Stewart GO, Gutteridge DH, Price RI, Ward L, Retallack RW, Prince RL, Stuckey BG, Kent GN, Bhagat CI, Dhaliwal SS (1999) Prevention of appendicular bone loss in Paget\u2019s disease following treatment with intravenous pamidronate disodium. Bone (NY) 24:139\u2013144","journal-title":"Bone (NY)"},{"key":"198_CR24","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1007\/s00520-009-0704-5","volume":"17","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Anastasilakis AD, Terpos E (2009) Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid. Support Care Cancer 17:1329\u20131330","journal-title":"Support Care Cancer"},{"issue":"suppl 2","key":"198_CR25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1359\/jbmr.06s204","volume":"21","author":"S Shankar","year":"2006","unstructured":"Shankar S, Hosking DJ (2006) Biochemical assessment of Paget\u2019s disease of bone. J Bone Miner Res 21(suppl 2):22\u201327","journal-title":"J Bone Miner Res"},{"key":"198_CR26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1055\/s-0029-1233491","volume":"41","author":"SA Polyzos","year":"2009","unstructured":"Polyzos SA, Anastasilakis AD, Efstathiadou Z, Kita M, Litsas I, Avramidis A, Arsos G, Moralidis E, Gerou S, Pavlidou V, Papatheodorou A, Terpos E (2009) The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin and RANKL in patients with Paget\u2019s disease of bone. Horm Metab Res 41:846\u2013850","journal-title":"Horm Metab Res"}],"container-title":["Journal of Bone and Mineral Metabolism"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-010-0198-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-010-0198-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-010-0198-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:16:40Z","timestamp":1559110600000},"score":1.0,"issued":{"date-parts":[[2010,6,9]]},"references-count":26,"journal-issue":{"published-print":{"date-parts":[[2010,11]]},"issue":"6"},"alternative-id":["198"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00774-010-0198-8","relation":{"cites":[]},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T18:04:53Z","timestamp":1574445893918},"reference-count":36,"publisher":"SAGE Publications","issue":"9","license":[{"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license","start":{"date-parts":[[2010,7,16]],"date-time":"2010-07-16T00:00:00Z","timestamp":1279238400000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mult Scler"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1177\/1352458510375708","type":"journal-article","created":{"date-parts":[[2010,7,17]],"date-time":"2010-07-17T00:50:29Z","timestamp":1279327829000},"page":"1091-1101","source":"Crossref","is-referenced-by-count":17,"title":["Familial prevalence of autoimmune disorders in multiple sclerosis in Northern Greece"],"prefix":"10.1177","volume":"16","author":[{"given":"Georgia","family":"Deretzi","sequence":"first","affiliation":[{"name":"Department of Neurology, Multiple Sclerosis Unit, Papageorgiou General Hospital, Thessaloniki, Greece,"}]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[{"name":"Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Evangelos","family":"Koutlas","sequence":"additional","affiliation":[{"name":"Department of Neurology, Multiple Sclerosis Unit, Papageorgiou General Hospital, Thessaloniki, Greece"}]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[{"name":"Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Stergios","family":"Polyzos","sequence":"additional","affiliation":[{"name":"Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Jobst","family":"Rudolf","sequence":"additional","affiliation":[{"name":"Department of Neurology, Multiple Sclerosis Unit, Papageorgiou General Hospital, Thessaloniki, Greece"}]},{"given":"Nikolaos","family":"Grigoriadis","sequence":"additional","affiliation":[{"name":"B\u2032 Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece"}]},{"given":"Emmanuel","family":"Gavalas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Marina","family":"Boziki","sequence":"additional","affiliation":[{"name":"Department of Medicine, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece"}]},{"given":"Iakovos","family":"Tsiptsios","sequence":"additional","affiliation":[{"name":"Department of Neurology, Multiple Sclerosis Unit, Papageorgiou General Hospital, Thessaloniki, Greece"}]}],"member":"179","published-online":{"date-parts":[[2010,7,16]]},"reference":[{"issue":"1","key":"atypb1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1212\/WNL.0b013e3181c97c8f","volume":"74","author":"Kasper LH","year":"2010","journal-title":"Neurology"},{"key":"atypb2","author":"McFarland HF","volume":"8","first-page":"913","year":"2007","journal-title":"Nat Immunol","DOI":"10.1038\/ni1507","doi-asserted-by":"crossref"},{"key":"atypb3","author":"Sadovnick AD","volume":"286","first-page":"1","year":"2009","journal-title":"J Neurol Sci","DOI":"10.1016\/j.jns.2009.09.005","doi-asserted-by":"crossref"},{"key":"atypb4","author":"Vukusic S.","volume":"127","first-page":"1353","year":"2004","journal-title":"Brain","DOI":"10.1093\/brain\/awh152","doi-asserted-by":"crossref"},{"key":"atypb5","author":"Lassmann H.","volume":"21","first-page":"242","year":"2008","journal-title":"Curr Opin Neurol","DOI":"10.1097\/WCO.0b013e3282fee94a","doi-asserted-by":"crossref"},{"key":"atypb6","author":"Weiner HL","volume":"65","first-page":"239","year":"2009","journal-title":"Ann Neurol","DOI":"10.1002\/ana.21640","doi-asserted-by":"crossref"},{"key":"atypb7","author":"Nielsen NM","volume":"63","first-page":"1001","year":"2006","journal-title":"Arch Neurol","DOI":"10.1001\/archneur.63.7.1001","doi-asserted-by":"crossref"},{"key":"atypb8","author":"Sloka JS","volume":"9","first-page":"2","year":"2005","journal-title":"J Autoimmune Dis"},{"key":"atypb9","author":"Annunziata P.","volume":"108","first-page":"327","year":"2003","journal-title":"Acta Neurol Scand","DOI":"10.1034\/j.1600-0404.2003.00158.x","doi-asserted-by":"crossref"},{"key":"atypb10","author":"Cohen R.","volume":"14","first-page":"738","year":"2008","journal-title":"Inflamm Bowel Dis","DOI":"10.1002\/ibd.20406","doi-asserted-by":"crossref"},{"key":"atypb11","author":"Barcellos LF","volume":"5","first-page":"924","year":"2006","journal-title":"Lancet Neurol","DOI":"10.1016\/S1474-4422(06)70552-X","doi-asserted-by":"crossref"},{"key":"atypb12","author":"Henderson RD","volume":"7","first-page":"434","year":"2000","journal-title":"J Clin Neurosci","DOI":"10.1054\/jocn.2000.0693","doi-asserted-by":"crossref"},{"key":"atypb13","author":"Heinzlef O.","volume":"101","first-page":"36","year":"2000","journal-title":"Acta Neurol Scand","DOI":"10.1034\/j.1600-0404.2000.101001036.x","doi-asserted-by":"crossref"},{"key":"atypb14","author":"Broadley SA","volume":"123","first-page":"1102","year":"2000","journal-title":"Brain","DOI":"10.1093\/brain\/123.6.1102","doi-asserted-by":"crossref"},{"key":"atypb15","DOI":"10.1177\/1352458508088936","doi-asserted-by":"publisher"},{"key":"atypb16","author":"Laufer TM","volume":"119","first-page":"2852","year":"2009","journal-title":"J Clin Invest","DOI":"10.1172\/JCI40986","doi-asserted-by":"crossref"},{"key":"atypb17","author":"McDonald WI","volume":"50","first-page":"121","year":"2001","journal-title":"Ann Neurol","DOI":"10.1002\/ana.1032","doi-asserted-by":"crossref"},{"key":"atypb18","author":"Somers EC","volume":"169","first-page":"749","year":"2009","journal-title":"Am J Epidemiol","DOI":"10.1093\/aje\/kwn408","doi-asserted-by":"crossref"},{"key":"atypb19","author":"Cooper GS","volume":"3","first-page":"197","year":"2009","journal-title":"J Autoimmun","DOI":"10.1016\/j.jaut.2009.09.008","doi-asserted-by":"crossref"},{"key":"atypb20","author":"Sawcer S.","volume":"67","first-page":"3","year":"2010","journal-title":"Ann Neurol","DOI":"10.1002\/ana.21911","doi-asserted-by":"crossref"},{"key":"atypb21","author":"Hewagama A.","volume":"33","first-page":"3","year":"2009","journal-title":"J Autoimmun","DOI":"10.1016\/j.jaut.2009.03.007","doi-asserted-by":"crossref"},{"key":"atypb22","author":"Gavalas E.","volume":"188","first-page":"187","year":"2007","journal-title":"J Neuroimmunol","DOI":"10.1016\/j.jneuroim.2007.06.007","doi-asserted-by":"crossref"},{"key":"atypb23","author":"Deretzi G.","volume":"73","first-page":"781","year":"2009","journal-title":"Med Hypotheses","DOI":"10.1016\/j.mehy.2009.04.021","doi-asserted-by":"crossref"},{"key":"atypb24","author":"Burdick LM","volume":"8","first-page":"459","year":"2009","journal-title":"Expert Opin Drug Saf","DOI":"10.1517\/14740330903066726","doi-asserted-by":"crossref"},{"key":"atypb25","author":"Garg N.","volume":"187","first-page":"159","year":"2007","journal-title":"J Neuroimmunol","DOI":"10.1016\/j.jneuroim.2007.04.008","doi-asserted-by":"crossref"},{"key":"atypb26","author":"Eggert M.","volume":"16","first-page":"1634","year":"2010","journal-title":"Curr Pharm Des","DOI":"10.2174\/138161210791164144","doi-asserted-by":"crossref"},{"key":"atypb27","author":"Caraccio N.","volume":"19","first-page":"149","year":"2009","journal-title":"Thyroid","DOI":"10.1089\/thy.2008.0290","doi-asserted-by":"crossref"},{"key":"atypb28","author":"Durelli L.","volume":"86","first-page":"3525","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"atypb29","author":"Polman CH","volume":"64","first-page":"996","year":"2005","journal-title":"Neurology","DOI":"10.1212\/01.WNL.0000154522.86947.86","doi-asserted-by":"crossref"},{"key":"atypb30","author":"Coles AJ","volume":"354","first-page":"1691","year":"1999","journal-title":"Lancet","DOI":"10.1016\/S0140-6736(99)02429-0","doi-asserted-by":"crossref"},{"key":"atypb31","author":"CAMMS223 Trial Investigators","volume":"359","first-page":"1786","year":"2008","journal-title":"N Engl J Med","DOI":"10.1056\/NEJMoa0802670","doi-asserted-by":"crossref"},{"key":"atypb32","author":"Lo-Pez-Lerma I.","volume":"160","first-page":"716","year":"2009","journal-title":"Br J Dermatol","DOI":"10.1111\/j.1365-2133.2008.09005.x","doi-asserted-by":"crossref"},{"key":"atypb33","author":"Fromont A.","volume":"45","first-page":"55","year":"2009","journal-title":"Cytokine","DOI":"10.1016\/j.cyto.2008.11.002","doi-asserted-by":"crossref"},{"key":"atypb34","author":"Kocer B.","volume":"16","first-page":"78","year":"2009","journal-title":"Eur J Neurol","DOI":"10.1111\/j.1468-1331.2009.02563.x","doi-asserted-by":"crossref"},{"key":"atypb35","author":"Schott E.","volume":"13","first-page":"3638","year":"2007","journal-title":"World J Gastroenterol","DOI":"10.3748\/wjg.v13.i26.3638","doi-asserted-by":"crossref"},{"key":"atypb36","author":"Charach G.","volume":"77","first-page":"198","year":"2008","journal-title":"Digestion","DOI":"10.1159\/000143156","doi-asserted-by":"crossref"}],"container-title":["Multiple Sclerosis Journal"],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458510375708","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1352458510375708","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T07:33:57Z","timestamp":1556782437000},"score":1.0,"issued":{"date-parts":[[2010,7,16]]},"references-count":36,"journal-issue":{"published-online":{"date-parts":[[2010,7,9]]},"published-print":{"date-parts":[[2010,9]]},"issue":"9"},"alternative-id":["10.1177\/1352458510375708"],"URL":"http:\/\/dx.doi.org\/10.1177\/1352458510375708","relation":{"cites":[]},"ISSN":["1352-4585","1477-0970"],"issn-type":[{"value":"1352-4585","type":"print"},{"value":"1477-0970","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T21:18:17Z","timestamp":1574457497549},"reference-count":62,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Gastroenterology"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/mcg.0b013e3181ec5c66","type":"journal-article","created":{"date-parts":[[2010,8,20]],"date-time":"2010-08-20T12:26:19Z","timestamp":1282307179000},"page":"50-54","source":"Crossref","is-referenced-by-count":34,"title":["The Potential Adverse Role of Leptin Resistance in Nonalcoholic Fatty Liver Disease"],"prefix":"10.1097","volume":"45","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]}],"member":"276","container-title":["Journal of Clinical Gastroenterology"],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/jcge\/Fulltext\/10.1097\/MCG.0b013e3181ec5c66","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,3]],"date-time":"2019-03-03T22:14:01Z","timestamp":1551651241000},"score":1.0,"subtitle":["A Hypothesis Based on Critical Review of the Literature"],"issued":{"date-parts":[[2011,1]]},"references-count":62,"journal-issue":{"issue":"1"},"URL":"http:\/\/dx.doi.org\/10.1097\/mcg.0b013e3181ec5c66","ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}]},{"indexed":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T23:29:51Z","timestamp":1574465391419},"reference-count":32,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Endocrinology & Metabolism"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1586\/eem.10.50","type":"journal-article","created":{"date-parts":[[2010,9,17]],"date-time":"2010-09-17T15:00:22Z","timestamp":1284735622000},"page":"673-679","source":"Crossref","is-referenced-by-count":1,"title":["Infectious thyroiditis as a complication of fine-needle biopsy: a systematic review"],"prefix":"10.1586","volume":"5","author":[{"given":"Stergios A","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Athanasios D","family":"Anastasilakis","sequence":"additional","affiliation":[]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","DOI":"10.1530\/eje.1.02158","doi-asserted-by":"publisher"},{"key":"CIT0002","volume":"12","first-page":"63","year":"2006","journal-title":"Endocr. Pract."},{"key":"CIT0003","author":"Polyzos","volume":"116","first-page":"496","year":"2008","journal-title":"Exp. Clin. Endocrinol. Diabetes","DOI":"10.1055\/s-2008-1058082","doi-asserted-by":"crossref"},{"key":"CIT0004","author":"Cooper","volume":"19","first-page":"1167","year":"2009","journal-title":"Thyroid","DOI":"10.1089\/thy.2009.0110","doi-asserted-by":"crossref"},{"key":"CIT0005","author":"Polyzos","volume":"6","first-page":"101","year":"2007","journal-title":"Hormones (Athens)","DOI":"10.14310\/horm.2002.111107","doi-asserted-by":"crossref"},{"key":"CIT0006","author":"Polyzos","volume":"71","first-page":"157","year":"2009","journal-title":"Clin. Endocrinol. (Oxf)","DOI":"10.1111\/j.1365-2265.2009.03522.x","doi-asserted-by":"crossref"},{"key":"CIT0007","author":"Polyzos","volume":"34","first-page":"844","year":"2010","journal-title":"World J. Surg.","DOI":"10.1007\/s00268-009-0362-2","doi-asserted-by":"crossref"},{"key":"CIT0008","author":"Polyzos","year":"2010","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"CIT0009","author":"Polyzos","volume":"37","first-page":"455","year":"2009","journal-title":"Diagn. Cytopathol.","DOI":"10.1002\/dc.21055","doi-asserted-by":"crossref"},{"key":"CIT0010","author":"Polyzos","volume":"20","first-page":"265","year":"2010","journal-title":"Thyroid","DOI":"10.1089\/thy.2009.0157","doi-asserted-by":"crossref"},{"key":"CIT0011","author":"Singh","volume":"73","first-page":"415","year":"1994","journal-title":"Ear Nose Throat J.","DOI":"10.1177\/014556139407301110","doi-asserted-by":"crossref"},{"key":"CIT0012","author":"Shah","volume":"2","first-page":"147","year":"2000","journal-title":"Curr. Infect. Dis. Rep.","DOI":"10.1007\/s11908-000-0027-7","doi-asserted-by":"crossref"},{"key":"CIT0013","author":"Chen","volume":"50","first-page":"217","year":"2006","journal-title":"Acta Cytol.","DOI":"10.1159\/000325936","doi-asserted-by":"crossref"},{"key":"CIT0014","author":"Isenberg","volume":"111","first-page":"832","year":"1994","journal-title":"J. Otolaryngol. Head Neck Surg.","DOI":"10.1016\/S0194-5998(94)70577-1","doi-asserted-by":"crossref"},{"key":"CIT0015","author":"Khoo","volume":"14","first-page":"426","year":"2008","journal-title":"Endocr. Pract.","DOI":"10.4158\/EP.14.4.426","doi-asserted-by":"crossref"},{"key":"CIT0016","author":"Nishihara","volume":"15","first-page":"1183","year":"2005","journal-title":"Thyroid","DOI":"10.1089\/thy.2005.15.1183","doi-asserted-by":"crossref"},{"key":"CIT0017","author":"Quinn","volume":"5","first-page":"619","year":"1994","journal-title":"J. Vasc. Interv. Radiol.","DOI":"10.1016\/S1051-0443(94)71565-7","doi-asserted-by":"crossref"},{"key":"CIT0018","author":"Sun","volume":"24","first-page":"84","year":"2002","journal-title":"Head Neck","DOI":"10.1002\/hed.1153","doi-asserted-by":"crossref"},{"key":"CIT0019","author":"Wang","volume":"25","first-page":"745","year":"1997","journal-title":"Clin. Infect. Dis.","DOI":"10.1086\/516943","doi-asserted-by":"crossref"},{"key":"CIT0020","volume":"10","first-page":"353","year":"2004","journal-title":"Endocr. Pract.","DOI":"10.4158\/EP.10.4.353","doi-asserted-by":"crossref"},{"key":"CIT0021","author":"Slatosky","volume":"61","first-page":"1054","year":"2000","journal-title":"Am. Fam. Physician"},{"key":"CIT0022","author":"Berger","volume":"5","first-page":"108","year":"1983","journal-title":"Rev. Infect. Dis.","DOI":"10.1093\/clinids\/5.1.108","doi-asserted-by":"crossref"},{"key":"CIT0023","author":"Herndon","volume":"73","first-page":"725","year":"2007","journal-title":"Am. Surg."},{"key":"CIT0024","author":"Faibis","volume":"9","first-page":"529","year":"2008","journal-title":"Surg. Infect. (Larchmt.)","DOI":"10.1089\/sur.2007.069","doi-asserted-by":"crossref"},{"key":"CIT0025","author":"Miyauchi","volume":"14","first-page":"400","year":"1990","journal-title":"World J. Surg.","DOI":"10.1007\/BF01658538","doi-asserted-by":"crossref"},{"key":"CIT0026","author":"Alvarado","volume":"32","first-page":"1341","year":"2008","journal-title":"World J. Surg.","DOI":"10.1007\/s00268-008-9554-4","doi-asserted-by":"crossref"},{"key":"CIT0027","author":"Watters","volume":"77","first-page":"933","year":"2007","journal-title":"ANZ J Surg.","DOI":"10.1111\/j.1445-2197.2007.04286.x","doi-asserted-by":"crossref"},{"key":"CIT0028","author":"Bergenfelz","volume":"393","first-page":"667","year":"2008","journal-title":"Langenbecks Arch. Surg.","DOI":"10.1007\/s00423-008-0366-7","doi-asserted-by":"crossref"},{"key":"CIT0029","author":"Sai Prasad","volume":"23","first-page":"779","year":"2007","journal-title":"Pediatr. Surg. Int.","DOI":"10.1007\/s00383-007-1939-1","doi-asserted-by":"crossref"},{"key":"CIT0030","author":"Polyzos","volume":"117","first-page":"159","year":"2009","journal-title":"Exp. Clin. Endocrinol. Diabetes","DOI":"10.1055\/s-2008-1080922","doi-asserted-by":"crossref"},{"key":"CIT0031","author":"Yu","volume":"27","first-page":"1286","year":"1998","journal-title":"Clin. Infect. Dis.","DOI":"10.1086\/514998","doi-asserted-by":"crossref"},{"key":"CIT0032","author":"Pitman","volume":"36","first-page":"407","year":"2008","journal-title":"Diagn. Cytopathol.","DOI":"10.1002\/dc.20829","doi-asserted-by":"crossref"}],"container-title":["Expert Review of Endocrinology & Metabolism"],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/eem.10.50","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T21:46:35Z","timestamp":1559684795000},"score":1.0,"issued":{"date-parts":[[2010,9]]},"references-count":32,"journal-issue":{"published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2010,9]]},"issue":"5"},"alternative-id":["10.1586\/eem.10.50"],"URL":"http:\/\/dx.doi.org\/10.1586\/eem.10.50","relation":{"cites":[]},"ISSN":["1744-6651","1744-8417"],"issn-type":[{"value":"1744-6651","type":"print"},{"value":"1744-8417","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T01:36:22Z","timestamp":1574472982196},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.metabol.2010.09.003","type":"journal-article","created":{"date-parts":[[2010,10,31]],"date-time":"2010-10-31T08:16:43Z","timestamp":1288513003000},"page":"313-326","source":"Crossref","is-referenced-by-count":134,"title":["Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"60","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Konstantinos A.","family":"Toulis","sequence":"additional","affiliation":[]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Metabolism"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049510003276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049510003276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T04:30:33Z","timestamp":1544157033000},"score":1.0,"issued":{"date-parts":[[2011,3]]},"references-count":67,"journal-issue":{"published-print":{"date-parts":[[2011,3]]},"issue":"3"},"alternative-id":["S0026049510003276"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.metabol.2010.09.003","ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T01:09:56Z","timestamp":1574471396034},"reference-count":43,"publisher":"Elsevier BV","issue":"1-2","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":["jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.jneuroim.2010.09.022","type":"journal-article","created":{"date-parts":[[2010,10,21]],"date-time":"2010-10-21T09:25:33Z","timestamp":1287653133000},"page":"254-256","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of Helicobacter pylori on chronic hepatitis C-related cognitive dysfunction"],"prefix":"10.1016","volume":"233","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Emmanouel","family":"Gavalas","sequence":"additional","affiliation":[]},{"given":"Stergios","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Panagiotis","family":"Katsinelos","sequence":"additional","affiliation":[]},{"given":"Nikolaos","family":"Grigoriadis","sequence":"additional","affiliation":[]},{"given":"Evangelos","family":"Koutlas","sequence":"additional","affiliation":[]},{"given":"Jobst","family":"Rudolf","sequence":"additional","affiliation":[]},{"given":"Iakovos","family":"Tsiptsios","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Journal of Neuroimmunology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281000442X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557281000442X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T09:55:01Z","timestamp":1544176501000},"score":1.0,"issued":{"date-parts":[[2011,4]]},"references-count":43,"journal-issue":{"published-print":{"date-parts":[[2011,4]]},"issue":"1-2"},"alternative-id":["S016557281000442X"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.jneuroim.2010.09.022","ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Helicobacter pylori on chronic hepatitis C-related cognitive dysfunction","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.09.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T07:16:29Z","timestamp":1574493389698},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T00:00:00Z","timestamp":1297209600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1007\/s00223-011-9468-2","type":"journal-article","created":{"date-parts":[[2011,2,8]],"date-time":"2011-02-08T07:14:59Z","timestamp":1297149299000},"page":"402-408","source":"Crossref","is-referenced-by-count":11,"title":["No Effect of Rosuvastatin in the Zoledronate-Induced Acute-Phase Response"],"prefix":"10.1007","volume":"88","author":[{"given":"Polyzois","family":"Makras","sequence":"first","affiliation":[]},{"given":"Athanasios D.","family":"Anastasilakis","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Ilias","family":"Bisbinas","sequence":"additional","affiliation":[]},{"given":"Grigorios T.","family":"Sakellariou","sequence":"additional","affiliation":[]},{"given":"Socrates E.","family":"Papapoulos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,2,9]]},"reference":[{"key":"9468_CR1","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1210\/jc.2010-0597","volume":"95","author":"IR Reid","year":"2010","unstructured":"Reid IR, Gamble GD, Mesenbrink P, Lakatos P, Black DM (2010) Characterization of and risk factors for the acute-phase response after zoledronic acid. J Clin Endocrinol Metab 95:4380\u20134387","journal-title":"J Clin Endocrinol Metab"},{"key":"9468_CR2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/BF02556671","volume":"41","author":"S Adami","year":"1987","unstructured":"Adami S, Bhalla A, Dorizzi R, Montesanti F, Rosini S, Salvagno G, Lo Cascio V (1987) The acute-phase response after bisphosphonate administration. Calcif Tissue Int 41:326\u2013331","journal-title":"Calcif Tissue Int"},{"key":"9468_CR3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/jbmr.5650100617","volume":"10","author":"DH Schweitzer","year":"1995","unstructured":"Schweitzer DH, Oostendorp-van de Ruit M, Van der Pluijm G, Lowik CW, Papapoulos SE (1995) Interleukin-6 and the acute phase response during treatment of patients with Paget\u2019s disease with the nitrogen-containing bisphosphonate dimethylaminohydroxypropylidene bisphosphonate. J Bone Miner Res 10:956\u2013962","journal-title":"J Bone Miner Res"},{"key":"9468_CR4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s002239900353","volume":"61","author":"D Thiebaud","year":"1997","unstructured":"Thiebaud D, Sauty A, Burckhardt P, Leuenberger P, Sitzler L, Green JR, Kandra A, Zieschang J, Ibarra de Palacios P (1997) An in vitro and in vivo study of cytokines in the acute-phase response associated with bisphosphonates. Calcif Tissue Int 61:386\u2013392","journal-title":"Calcif Tissue Int"},{"key":"9468_CR5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/bmj.295.6609.1301","volume":"295","author":"HI Harinck","year":"1987","unstructured":"Harinck HI, Papapoulos SE, Blanksma HJ, Moolenaar AJ, Vermeij P, Bijvoet OL (1987) Paget\u2019s disease of bone: early and late responses to three different modes of treatment with aminohydroxypropylidene bisphosphonate (APD). Br Med J (Clin Res Ed) 295:1301\u20131305","journal-title":"Br Med J (Clin Res Ed)"},{"key":"9468_CR6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1006\/bbrc.1999.1499","volume":"264","author":"E Beek van","year":"1999","unstructured":"van Beek E, Pieterman E, Cohen L, L\u00f6wik C, Papapoulos S (1999) Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. Biochem Biophys Res Commun 264:108\u2013111","journal-title":"Biochem Biophys Res Commun"},{"key":"9468_CR7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1359\/jbmr.1999.14.5.722","volume":"14","author":"E Beek van","year":"1999","unstructured":"van Beek E, L\u00f6wik C, van der Pluijm G, Papapoulos S (1999) The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: a clue to the mechanism of action of nitrogen-containing bisphosphonates. J Bone Miner Res 14:722\u2013729","journal-title":"J Bone Miner Res"},{"key":"9468_CR8","doi-asserted-by":"crossref","first-page":"6222","DOI":"10.1158\/1078-0432.CCR-06-0843","volume":"12","author":"AJ Roelofs","year":"2006","unstructured":"Roelofs AJ, Thompson K, Gordon S, Rogers MJ (2006) Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 12:6222\u20136230","journal-title":"Clin Cancer Res"},{"key":"9468_CR9","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2141.2008.07435.x","volume":"144","author":"AJ Roelofs","year":"2009","unstructured":"Roelofs AJ, Jauhiainen M, M\u00f6nkk\u00f6nen H, Rogers MJ, M\u00f6nkk\u00f6nen J, Thompson K (2009) Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP\/DMAPP. Br J Haematol 144:245\u2013250","journal-title":"Br J Haematol"},{"key":"9468_CR10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1359\/JBMR.0301230","volume":"19","author":"K Thompson","year":"2004","unstructured":"Thompson K, Rogers MJ (2004) Statins prevent bisphosphonate-induced gdT-cell proliferation and activation in vitro. J Bone Miner Res 19:278\u2013288","journal-title":"J Bone Miner Res"},{"key":"9468_CR11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1359\/jbmr.081016","volume":"24","author":"T Srivastava","year":"2009","unstructured":"Srivastava T, Haney CJ, Alon US (2009) Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate Infusion. J Bone Miner Res 24:334\u2013337","journal-title":"J Bone Miner Res"},{"key":"9468_CR12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/art.1780231018","volume":"23","author":"OL Bijvoet","year":"1980","unstructured":"Bijvoet OL, Frijlink WB, Jie K, van der Linden H, Meijer CJ, Mulder H, van Paassen HC, Reitsma PH, te Velde J, de Vries E, van der Wey JP (1980) APD in Paget\u2019s disease of bone. Role of the mononuclear phagocyte system? Arthritis Rheum 23:1193\u20131204","journal-title":"Arthritis Rheum"},{"key":"9468_CR13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1359\/jbmr.090819","volume":"25","author":"F Bertoldo","year":"2010","unstructured":"Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M, Valenti MT, Carbonare LD, Lo Cascio V (2010) Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Miner Res 25:447\u2013454","journal-title":"J Bone Miner Res"},{"key":"9468_CR14","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","volume":"356","author":"DM Black","year":"2007","unstructured":"Black DM, Delmas PD, Eastell R, Reid IR, Boonen S, Cauley JA, Cosman F, Lakatos P, Leung PC, Man Z, Mautalen C, Mesenbrink P, Hu H, Caminis J, Tong K, Rosario-Jansen T, Krasnow J, Hue TF, Sellmeyer D, Eriksen EF, Cummings SR (2007) Once yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med 356:1809\u20131822","journal-title":"N Engl J Med"},{"key":"9468_CR15","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bone.2007.01.016","volume":"40","author":"K Saag","year":"2007","unstructured":"Saag K, Lindsay R, Kriegman A, Beamer E, Zhou W (2007) A single zoledronic acid infusion reduces bone resorption markers more rapidly than weekly oral alendronate in postmenopausal women with low bone mineral density. Bone 40:1238\u20131243","journal-title":"Bone"},{"key":"9468_CR16","first-page":"235","volume":"296","author":"JE Dunford","year":"2001","unstructured":"Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ (2001) Structure\u2013activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 296:235\u2013242","journal-title":"J Pharmacol Exp Ther"},{"key":"9468_CR17","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.amjcard.2006.11.036","volume":"99","author":"JL P\u00e9rez-Castrill\u00f3n","year":"2007","unstructured":"P\u00e9rez-Castrill\u00f3n JL, Vega G, Abad L, Sanz A, Chaves J, Hernandez G, Due\u00f1as A (2007) Effects of atorvastatin on vitamin D levels in patients with acute ischemic heart disease. Am J Cardiol 99:903\u2013905","journal-title":"Am J Cardiol"},{"key":"9468_CR18","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10557-009-6181-8","volume":"23","author":"B Yavuz","year":"2009","unstructured":"Yavuz B, Ertugrul DT, Cil H, Ata N, Akin KO, Yalcin AA, Kucukazman M, Dal K, Hokkaomeroglu MS, Yavuz BB, Tutal E (2009) Increased levels of 25 hydroxyvitamin D and 1,25-dihydroxyvitamin D after rosuvastatin treatment: a novel pleiotropic effect of statins? Cardiovasc Drugs Ther 23:295\u2013299","journal-title":"Cardiovasc Drugs Ther"},{"key":"9468_CR19","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.5551\/jat.5652","volume":"17","author":"SS Yoon","year":"2010","unstructured":"Yoon SS, Dillon CF, Carroll M, Illoh K, Ostchega Y (2010) Effects of statins on serum inflammatory markers: the U.S. National Health and Nutrition Examination Survey 1999\u20132004. J Atheroscler Thromb 17:1176\u20131182","journal-title":"J Atheroscler Thromb"},{"key":"9468_CR20","unstructured":"Thompson K, Keech F, McLernon DJ, Vinod K, May RJ, Simpson WG, Rogers MJ, Reid DM (2010) Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women. Bone. doi: 10.1016\/j.bone.2010.10.177","DOI":"10.1016\/j.bone.2010.10.177","doi-asserted-by":"crossref"},{"key":"9468_CR21","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1359\/jbmr.2003.18.1.88","volume":"18","author":"A Staal","year":"2003","unstructured":"Staal A, Frith JC, French MH, Swartz J, G\u00fcng\u00f6r T, Harrity TW, Tamasi J, Rogers MJ, Feyen JH (2003) The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity. J Bone Miner Res 18:88\u201396","journal-title":"J Bone Miner Res"}],"container-title":["Calcified Tissue International"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-011-9468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-011-9468-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-011-9468-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T11:52:11Z","timestamp":1559994731000},"score":1.0,"issued":{"date-parts":[[2011,2,9]]},"references-count":21,"journal-issue":{"published-print":{"date-parts":[[2011,5]]},"issue":"5"},"alternative-id":["9468"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00223-011-9468-2","relation":{"cites":[]},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T09:29:52Z","timestamp":1574501392631},"reference-count":15,"publisher":"Wiley","issue":"5","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1624,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1600-0404.2010.01456.x","type":"journal-article","created":{"date-parts":[[2011,3,23]],"date-time":"2011-03-23T00:43:38Z","timestamp":1300841018000},"page":"366-367","source":"Crossref","is-referenced-by-count":0,"title":["Irritable bowel syndrome associated with mitral valve prolapse and autonomic and haemostatic abnormalities in children, adolescents and adults with migraine"],"prefix":"10.1111","volume":"123","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Antonios","family":"Papadopoulos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Stergios","family":"Polyzos","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2011,3,22]]},"reference":[{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB1|cit1","first-page":"91","article-title":"Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study","volume":"122","author":"Termine","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB2|cit2","first-page":"107","article-title":"Mitral valve prolapse in patients with irritable bowel syndrome","volume":"192","author":"Kountouras","year":"1992","journal-title":"Sci Ann Fac Med"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-230X-6-26","article-title":"Migraine, fibromyalgia, and depression among people with IBS: a prevalence study","volume":"6","author":"Cole","year":"2006","journal-title":"BMC Gastroenterol"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1526-4610.2009.01558.x","article-title":"Childhood maltreatment and migraine (part III). Association with comorbid pain conditions","volume":"50","author":"Tietjen","year":"2010","journal-title":"Headache"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB5|cit5","first-page":"RA47","article-title":"Autonomic dysfunction and cardiac repolarization abnormalities in patients with migraine attacks","volume":"13","author":"Melek","year":"2007","journal-title":"Med Sci Monit"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1586\/14737175.8.9.1321","article-title":"Migraine genetics","volume":"8","author":"Montagna","year":"2008","journal-title":"Expert Rev Neurother"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1046\/j.1468-2982.2003.00441.x","article-title":"Central 5-HT receptor hypersensitivity in migraine without aura","volume":"23","author":"Cassidy","year":"2003","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1468-2982.2005.00916.x","article-title":"Platelet activation and platelet-leucocyte interaction in patients with migraine. Subtype differences and influence of triptans","volume":"25","author":"Zeller","year":"2005","journal-title":"Cephalalgia"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.neulet.2006.06.015","article-title":"Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation","volume":"404","author":"Tremolizzo","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11916-009-0063-4","article-title":"Platelet dysfunction and stroke in the female migraineur","volume":"13","author":"Tietjen","year":"2009","journal-title":"Curr Pain Headache Rep"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB11|cit11","first-page":"89","article-title":"Goshuyuto, a traditional Japanese medicine for migraine, inhibits platelet aggregation in guinea-pig whole blood","volume":"108","author":"Hibino","year":"2008","journal-title":"J Pharmacol"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00129784-200303030-00001","article-title":"Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction?","volume":"3","author":"Schlienger","year":"2003","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1136\/jnnp.2003.019638","article-title":"Platelet-leukocyte interaction and platelet activation in migraine: a link to ischemic stroke?","volume":"75","author":"Zeller","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2885.2008.00944.x","article-title":"Serotonin: a review","volume":"31","author":"Mohammad-Zadeh","year":"2008","journal-title":"J Vet Pharmacol Ther"},{"key":"10.1111\/j.1600-0404.2010.01456.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1053\/j.gastro.2010.03.032","article-title":"Serotonin signaling is altered in irritable bowel syndrome with diarrhea but not in functional dyspepsia in pediatric age patients","volume":"139","author":"Faure","year":"2010","journal-title":"Gastroenterology"}],"container-title":["Acta Neurologica Scandinavica"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0404.2010.01456.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,19]],"date-time":"2017-06-19T21:23:33Z","timestamp":1497907413000},"score":1.0,"subtitle":["Letter to the Editor"],"issued":{"date-parts":[[2011,3,22]]},"references-count":15,"journal-issue":{"published-print":{"date-parts":[[2011,5]]},"issue":"5"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1600-0404.2010.01456.x","relation":{"cites":[]},"ISSN":["0001-6314"],"issn-type":[{"value":"0001-6314","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T08:32:57Z","timestamp":1574497977697},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/","start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.exer.2011.02.017","type":"journal-article","created":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T13:48:02Z","timestamp":1299332882000},"page":"436-438","source":"Crossref","is-referenced-by-count":7,"title":["Neuroprotection in glaucoma: Is there a future role of Helicobacter pylori eradication?"],"prefix":"10.1016","volume":"92","author":[{"given":"Jannis","family":"Kountouras","sequence":"first","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Emmanuel","family":"Gavalas","sequence":"additional","affiliation":[]},{"given":"Elena","family":"Tsiaousi","sequence":"additional","affiliation":[]},{"given":"Evaggelia","family":"Giartza-Taxidou","sequence":"additional","affiliation":[]},{"given":"Dimitrios","family":"Chatzopoulos","sequence":"additional","affiliation":[]},{"given":"Stavros","family":"Michael","sequence":"additional","affiliation":[]},{"given":"George","family":"Tsarouchas","sequence":"additional","affiliation":[]}],"member":"78","container-title":["Experimental Eye Research"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483511000741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483511000741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T10:20:13Z","timestamp":1543918813000},"score":1.0,"issued":{"date-parts":[[2011,5]]},"references-count":31,"journal-issue":{"published-print":{"date-parts":[[2011,5]]},"issue":"5"},"alternative-id":["S0014483511000741"],"URL":"http:\/\/dx.doi.org\/10.1016\/j.exer.2011.02.017","ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T16:35:01Z","timestamp":1574526901020},"reference-count":17,"publisher":"Wiley","issue":"10","license":[{"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1","start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"delay-in-days":1506,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1111\/j.1751-7176.2011.00484.x","type":"journal-article","created":{"date-parts":[[2011,7,18]],"date-time":"2011-07-18T09:33:26Z","timestamp":1310981606000},"page":"783-784","source":"Crossref","is-referenced-by-count":0,"title":["Spironolactone Revisited"],"prefix":"10.1111","volume":"13","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"given":"Christos","family":"Zavos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2011,7,18]]},"reference":[{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1751-7176.2010.00339.x","article-title":"Aldosterone antagonist decreases blood pressure and improves metabolic parameters in obese patients with the metabolic syndrome","volume":"12","author":"Costa","year":"2010","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB2|cit2","author":"Polyzos","year":"2011","article-title":"Effect of spironolactone and vitamin E on serum metabolic parameters and insulin resistance in patients with nonalcoholic fatty liver disease","journal-title":"J Renin Angiotensin Aldosterone Syst","DOI":"10.1177\/1470320311402110","doi-asserted-by":"crossref"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/156652409787847191","article-title":"Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines","volume":"72","author":"Polyzos","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/en.2009-0869","article-title":"Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet","volume":"151","author":"Wada","year":"2010","journal-title":"Endocrinology"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3109\/10641960903407017","article-title":"Comparison of effects of low dose of spironolactone and a thiazide diuretic in patients with hypertension treated with an angiotensin-converting enzyme inhibitor or an angiotensin type 1 receptor blocker","volume":"31","author":"Yutaka","year":"2009","journal-title":"Clin Exp Hypertens"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/0002-9149(88)90551-6","article-title":"Long-term metabolic effects of spironolactone and thiazides combined with potassium-sparing agents for treatment of essential hypertension","volume":"62","author":"Jeunemaitre","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0954-6820.1983.tb03684.x","article-title":"The effect of spironolactone on lipid, glucose and uric acid levels in blood during long-term administration to hypertensives","volume":"213","author":"Falch","year":"1983","journal-title":"Acta Med Scand"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.metabol.2006.07.025","article-title":"The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy","volume":"55","author":"Matsumoto","year":"2006","journal-title":"Metabolism"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/BF03345529","article-title":"Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile","volume":"28","author":"Zulian","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB10|cit10","author":"Kebapcilar","year":"2009","article-title":"Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome","journal-title":"Arch Gynecol Obstet"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2125.2009.03483.x","article-title":"Short term effects of spironolactone on blood lipid profile: a 3-month study on a cohort of young women with hirsutism","volume":"68","author":"Nakhjavani","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-10-0709","article-title":"Influence of spironolactone treatment on endothelial function in non-obese women with polycystic ovary syndrome","volume":"164","author":"Studen","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/j.1552-4604.1991.tb01903.x","article-title":"Hydrochlorothiazide versus spironolactone: long-term metabolic modifications in patients with essential hypertension","volume":"31","author":"Garca","year":"1991","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4158\/EP.14.8.985","article-title":"Effect of spironolactone therapy on albuminuria in patients with type 2 diabetes treated with angiotensin-converting enzyme inhibitors","volume":"14","author":"Davidson","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1681\/ASN.2009070737","article-title":"Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy","volume":"20","author":"Mehdi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"449","DOI":"10.5414\/CNP72449","article-title":"Low-dose spironolactone, added to long-term ACE inhibitor therapy, reduces blood pressure and urinary albumin excretion in obese patients with hypertensive target organ damage","volume":"72","author":"Bomback","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1751-7176.2011.00484.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","article-title":"Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?","volume":"2","author":"Bansal","year":"2009","journal-title":"Circ Heart Fail"}],"container-title":["The Journal of Clinical Hypertension"],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1751-7176.2011.00484.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T03:18:29Z","timestamp":1497928709000},"score":1.0,"subtitle":["LETTER TO THE EDITOR"],"issued":{"date-parts":[[2011,7,18]]},"references-count":17,"journal-issue":{"published-print":{"date-parts":[[2011,10]]},"issue":"10"},"URL":"http:\/\/dx.doi.org\/10.1111\/j.1751-7176.2011.00484.x","relation":{"cites":[]},"ISSN":["1524-6175"],"issn-type":[{"value":"1524-6175","type":"print"}]},{"indexed":{"date-parts":[[2019,11,23]],"date-time":"2019-11-23T17:07:50Z","timestamp":1574528870384},"reference-count":0,"publisher":"FapUNIFESP (SciELO)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics"],"DOI":"10.1590\/s1807-59322011000500031","type":"journal-article","created":{"date-parts":[[2011,7,22]],"date-time":"2011-07-22T10:29:37Z","timestamp":1311330577000},"page":"911-912","source":"Crossref","is-referenced-by-count":6,"title":["The potentially dual-faceted nature of fetuin-A in Helicobacter pylori infection and insulin resistance"],"prefix":"10.1590","volume":"66","author":[{"given":"Stergios A.","family":"Polyzos","sequence":"first","affiliation":[]},{"given":"Jannis","family":"Kountouras","sequence":"additional","affiliation":[]},{"family":"Christos Zavos","sequence":"additional","affiliation":[]},{"given":"Georgia","family":"Deretzi","sequence":"additional","affiliation":[]}],"member":"530","published-online":{"date-parts":[[2011]]},"container-title":["Clinics"],"language":"en","link":[{"URL":"http:\/\/www.scielo.br\/pdf\/clin\/v66n5\/31.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,15]],"date-time":"2016-12-15T10:59:46Z","timestamp":1481799586000},"score":1.0,"issued":{"date-parts":[[2011]]},"references-count":0,"journal-issue":{"published-online":{"date-parts":[[2011]]},"issue":"5"},"alternative-id":["S1807-59322011000500031"],"URL":"http:\/\/dx.doi.org\/10.1590\/s1807-59322011000500031","ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}]},{"indexed":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T06:51:01Z","timestamp":1575269461018},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Endocrinology & Diabetes and Obesity"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/med.0b013e32834afff2","type":"journal-article","created":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T16:12:44Z","timestamp":1377879164000},"page":"383-388","source":"Crossref","is-referenced-by-count":12,"title":["Role of wingless tail signaling pathway in osteoporosis"],"prefix":"10.1097","volume":"18","author":[{"given":"Athanasios D.","family":"Anastasilakis","sequence":"first","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Konstantinos A.","family":"Toulis","sequence":"additional","affiliation":[]}],"member":"276","container-title":["Current Opinion in Endocrinology & Diabetes and Obesity"],"language":"en","deposited":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T21:02:36Z","timestamp":1498078956000},"score":1.0,"subtitle":["an update of current knowledge"],"issued":{"date-parts":[[2011,12]]},"references-count":47,"journal-issue":{"issue":"6"},"URL":"http:\/\/dx.doi.org\/10.1097\/med.0b013e32834afff2","ISSN":["1752-296X"],"issn-type":[{"value":"1752-296X","type":"print"}],"subject":["Internal Medicine","Nutrition and Dietetics","Endocrinology, Diabetes and Metabolism","Endocrinology"]},{"indexed":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T20:09:35Z","timestamp":1575317375011},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"URL":"http:\/\/www.springer.com\/tdm","start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"delay-in-days":0,"content-version":"tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1007\/s00774-008-0852-6","type":"journal-article","created":{"date-parts":[[2008,10,31]],"date-time":"2008-10-31T10:41:20Z","timestamp":1225449680000},"page":"635-641","source":"Crossref","is-referenced-by-count":16,"title":["Scintigraphic, biochemical, and clinical response to zoledronic acid treatment in patients with Paget\u2019s disease of bone"],"prefix":"10.1007","volume":"26","author":[{"given":"Avraam","family":"Avramidis","sequence":"first","affiliation":[]},{"given":"Stergios A.","family":"Polyzos","sequence":"additional","affiliation":[]},{"given":"Efstratios","family":"Moralidis","sequence":"additional","affiliation":[]},{"given":"Georgios","family":"Arsos","sequence":"additional","affiliation":[]},{"given":"Zoe","family":"Efstathiadou","sequence":"additional","affiliation":[]},{"given":"Konstantinos","family":"Karakatsanis","sequence":"additional","affiliation":[]},{"given":"Georgios","family":"Grollios","sequence":"additional","affiliation":[]},{"given":"Marina","family":"Kita","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2008,11,1]]},"reference":[{"key":"852_CR1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S8756-3282(02)00817-7","volume":"31","author":"P.L. Selby","year":"2002","unstructured":"Selby PL, Davie MW, Ralston SH, Stone MD (2002) Guidelines on the management of Paget\u2019s disease of bone. Bone (NY) 31:366\u2013373","journal-title":"Bone (NY)"},{"key":"852_CR2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00774-006-0696-x","volume":"24","author":"S. Takata","year":"2006","unstructured":"Takata S, Hashimoto J, Nakatsuka K, Yoshimura N, Yoh K, Ohno I, Yabe H, Abe S, Fukunaga M, Terada M, Zamma M, Ralston SH, Morii H, Yoshikawa H (2006) Guidelines for diagnosis and management of Paget\u2019s disease of bone in Japan. J Bone Miner Metab 24:359\u2013367","journal-title":"J Bone Miner Metab"},{"issue":"suppl2","key":"852_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1359\/jbmr.06s201","volume":"21","author":"C. Cooper","year":"2006","unstructured":"Cooper C, Harvey NC, Dennison EM, van Staa TP (2006) Update on the epidemiology of Paget\u2019s disease of bone. J Bone Miner Res 21(suppl 2):3\u20138","journal-title":"J Bone Miner Res"},{"issue":"suppl2","key":"852_CR4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1359\/jbmr.06s203","volume":"21","author":"L. Gennari","year":"2006","unstructured":"Gennari L, Merlotti D, Martini G, Nuti R (2006) Paget\u2019s disease of bone in Italy. J Bone Miner Res 21(suppl 2):14\u201321","journal-title":"J Bone Miner Res"},{"issue":"suppl2","key":"852_CR5","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1359\/jbmr.06s217","volume":"21","author":"P.L. Selby","year":"2006","unstructured":"Selby PL (2006) Guidelines for the diagnosis and management of Paget\u2019s disease: a UK perspective. J Bone Miner Res 21(suppl 2):92\u201393","journal-title":"J Bone Miner Res"},{"key":"852_CR6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1359\/jbmr.061001","volume":"22","author":"D. Hosking","year":"2007","unstructured":"Hosking D, Lyles K, Brown JP, Fraser WD, Miller P, Curiel MD, Devogelaer JP, Hooper M, Su G, Zelenakas K, Pak J, Fashola T, Saidi Y, Eriksen EF, Reid IR (2007) Long-term control of bone turnover in Paget\u2019s disease with zoledronic acid and risedronate. J Bone Miner Res 22:142\u2013148","journal-title":"J Bone Miner Res"},{"key":"852_CR7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJMoa044241","volume":"353","author":"I.R. Reid","year":"2005","unstructured":"Reid IR, Miller P, Lyles K, Fraser W, Brown JP, Saidi Y, Mesenbrink P, Su G, Pak J, Zelenakas K, Luchi M, Richardson P, Hosking D (2005) Comparison of a single infusion of zoledronic acid with risedronate for Paget\u2019s disease. N Engl J Med 353: 898\u2013908","journal-title":"N Engl J Med"},{"issue":"suppl2","key":"852_CR8","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1359\/jbmr.06s215","volume":"21","author":"I.R. Reid","year":"2006","unstructured":"Reid IR (2006) Zoledronate: efficacy and safety. J Bone Miner Res 21(suppl 2):83\u201387","journal-title":"J Bone Miner Res"},{"issue":"suppl2","key":"852_CR9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1359\/jbmr.06s218","volume":"21","author":"E.S. Siris","year":"2006","unstructured":"Siris ES, Lyles KW, Singer FR, Meunier PJ (2006) Medical management of Paget\u2019s disease of bone: indications for treatment and review of current therapies. J Bone Miner Res 21(suppl 2):94\u201398","journal-title":"J Bone Miner Res"},{"key":"852_CR10","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/00003495-200767050-00011","volume":"67","author":"G.M. Keating","year":"2007","unstructured":"Keating GM, Scott LJ (2007) Zoledronic acid: a review of its use in the treatment of Paget\u2019s disease of bone. Drugs 67:793\u2013804","journal-title":"Drugs"},{"key":"852_CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bone.2005.05.003","volume":"38","author":"G.H. Nancollas","year":"2006","unstructured":"Nancollas GH, Tang R, Phipps RJ, Henneman Z, Gulde S, Wu W, Mangood A, Russell RG, Ebetino FH (2006) Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite. Bone (NY) 38:617\u2013627","journal-title":"Bone (NY)"},{"key":"852_CR12","first-page":"235","volume":"296","author":"J.E. Dunford","year":"2001","unstructured":"Dunford JE, Thompson K, Coxon FP, Luckman SP, Hahn FM, Poulter CD, Ebetino FH, Rogers MJ (2001) Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. J Pharmacol Exp Ther 296:235\u2013242","journal-title":"J Pharmacol Exp Ther"},{"key":"852_CR13","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1007\/s00223-007-9012-6","volume":"80","author":"J. Shapiro","year":"2007","unstructured":"Shapiro J, Smith B, Beck T, Ballard P, Dapthary M, BrintzenhofeSzoc K, Caminis J (2007) Treatment with zoledronic acid ameliorates negative geometric changes in the proximal femur following acute spinal cord injury. Calcif Tissue Int 80:316\u2013322","journal-title":"Calcif Tissue Int"},{"key":"852_CR14","first-page":"464","volume":"25","author":"K. Tziomalos","year":"2007","unstructured":"Tziomalos K, Florentin M, Krikis N, Perifanis V, Karagiannis A, Harsoulis F (2007) Persistent effect of zoledronic acid in Paget\u2019s disease. Clin Exp Rheumatol 25:464\u2013466","journal-title":"Clin Exp Rheumatol"},{"key":"852_CR15","first-page":"1359","volume":"42","author":"J.A. Carrasquillo","year":"2001","unstructured":"Carrasquillo JA, Whatley M, Dyer V, Figg WD, Dahut W (2001) Alendronate does not interfere with 99mTc-methylene diphosphonate bone scanning. J Nucl Med 42:1359\u20131363","journal-title":"J Nucl Med"},{"key":"852_CR16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00006231-199011000-00004","volume":"11","author":"U. Patel","year":"1990","unstructured":"Patel U, Gallacher SJ, Boyle IT, McKillop JH (1990) Serial bone scans in Paget\u2019s disease: development of new lesions, natural variation in lesion intensity and nature of changes seen after treatment. Nucl Med Commun 11:747\u2013760","journal-title":"Nucl Med Commun"},{"key":"852_CR17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1259\/0007-1285-58-696-1165","volume":"58","author":"C.J. Vellenga","year":"1985","unstructured":"Vellenga CJ, Pauwels EK, Bijvoet OL, Harinck HI, Frijlink WB (1985) Quantitative bone scintigraphy in Paget\u2019s disease treated with APD. Br J Radiol 58:1165\u20131172","journal-title":"Br J Radiol"},{"key":"852_CR18","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/00006231-199906000-00006","volume":"20","author":"F. Pons","year":"1999","unstructured":"Pons F, Alvarez L, Peris P, Guanabens N, Vidal-Sicart S, Monegal A, Pavia J, Ballesta AM, Munos-Gomez J, Herranz R (1999) Quantitative evaluation of bone scintigraphy in the assessment of Paget\u2019s disease activity. Nucl Med Commun 20:525\u2013528","journal-title":"Nucl Med Commun"},{"key":"852_CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1259\/0007-1285-50-592-243","volume":"50","author":"J.P. Lavender","year":"1977","unstructured":"Lavender JP, Evans IM, Arnot R, Bowring S, Doyle FH, Joplin GF, MacIntyre I (1977) A comparison of radiography and radioisotope scanning in the detection of Paget\u2019s disease and in the assessment of response to human calcitonin. Br J Radiol 50: 243\u2013250","journal-title":"Br J Radiol"},{"key":"852_CR20","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1148\/125.3.761","volume":"125","author":"A.D. Waxman","year":"1977","unstructured":"Waxman AD, Ducker S, McKee D, Siemsen JK, Singer FR (1977) Evaluation of 99mTc diphosphonate kinetics and bone scans in patients with Paget\u2019s disease before and after calcitonin treatment. Radiology 125:761\u2013764","journal-title":"Radiology"},{"key":"852_CR21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0009-9260(76)80037-2","volume":"27","author":"B.C. Lentle","year":"1976","unstructured":"Lentle BC, Russell AS, Heslip PG, Percy JS (1976) The scintigraphic findings in Paget\u2019s disease of bone. Clin Radiol 27: 129\u2013135","journal-title":"Clin Radiol"},{"key":"852_CR22","first-page":"94","volume":"127","author":"M. Rashid","year":"1977","unstructured":"Rashid M, Khairi A, Johnston C Jr (1977) Treatment of Paget\u2019s disease of bone (osteitis deformans) with sodium etidronate (EHDP). Clin Orthop Relat Res 127:94\u2013105","journal-title":"Clin Orthop Relat Res"},{"key":"852_CR23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4158\/EP.9.4.280","volume":"9","author":"G. Ang","year":"2003","unstructured":"Ang G, Feiglin D, Moses AM (2003) Symptomatic and scintigraphic improvement after intravenous pamidronate treatment of Paget\u2019s disease of bone in patients with normal serum alkaline phosphatase levels. Endocr Pract 9:280\u2013283","journal-title":"Endocr Pract"},{"key":"852_CR24","first-page":"1589","volume":"33","author":"P.J. Ryan","year":"1992","unstructured":"Ryan PJ, Gibson T, Fogelman I (1992) Bone scintigraphy following intravenous pamidronate for Paget\u2019s disease of bone. J Nucl Med 33:1589\u20131593","journal-title":"J Nucl Med"},{"key":"852_CR25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.bone.2004.03.023","volume":"35","author":"I.R. Reid","year":"2004","unstructured":"Reid IR, Davidson JS, Wattie D, Wu F, Lucas J, Gamble GD, Rutland MD, Cundy T (2004) Comparative responses of bone turnover markers to bisphosphonate therapy in Paget\u2019s disease of bone. Bone (NY) 35:224\u2013230","journal-title":"Bone (NY)"},{"key":"852_CR26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0221-8747(81)90040-0","volume":"3","author":"I. Fogelman","year":"1981","unstructured":"Fogelman I, Carr D, Boyle IT (1981) The role of bone scanning in Paget\u2019s disease. Metab Bone Dis Relat Res 3:243\u2013254","journal-title":"Metab Bone Dis Relat Res"},{"key":"852_CR27","first-page":"154","volume":"3","author":"C.J. Vellenga","year":"1988","unstructured":"Vellenga CJ, Bijvoet OL, Pauwels EK (1988) Bone scintigraphy and radiology in Paget\u2019s disease of bone: a review. Am J Physiol Imaging 3:154\u2013168","journal-title":"Am J Physiol Imaging"},{"key":"852_CR28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1210\/jcem-42-3-459","volume":"42","author":"A. Avramides","year":"1976","unstructured":"Avramides A, Flores A, DeRose J, Wallach S (1976) Paget\u2019s disease of the bone: observations after cessation of long-term synthetic salmon calcitonin treatment. J Clin Endocrinol Metab 42:459\u2013463","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl2","key":"852_CR29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1359\/jbmr.06s216","volume":"21","author":"S.E. Papapoulos","year":"2006","unstructured":"Papapoulos SE, Eekhoff EM, Zwinderman AH (2006) Acquired resistance to bisphosphonates in Paget\u2019s disease of bone. J Bone Miner Res 21(suppl 2):88\u201391","journal-title":"J Bone Miner Res"},{"key":"852_CR30","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1359\/jbmr.070704","volume":"22","author":"D. Merlotti","year":"2007","unstructured":"Merlotti D, Gennari L, Martini G, Valleggi F, De PV, Avanzati A, Nuti R (2007) Comparison of different intravenous bisphosphonate regimens for Paget\u2019s disease of bone. J Bone Miner Res 22:1510\u20131517","journal-title":"J Bone Miner Res"},{"key":"852_CR31","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1359\/jbmr.2003.18.5.868","volume":"18","author":"S.C. Cremers","year":"2003","unstructured":"Cremers SC, Eekhoff ME, Den HJ, Hamdy NA, Vermeij P, Papapoulos SE (2003) Relationships between pharmacokinetics and rate of bone turnover after intravenous bisphosphonate (olpadronate) in patients with Paget\u2019s disease of bone. J Bone Miner Res 18:868\u2013875","journal-title":"J Bone Miner Res"},{"key":"852_CR32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/jbmr.5650070308","volume":"7","author":"M.D. Stone","year":"1992","unstructured":"Stone MD, Marshall DH, Hosking DJ, Perkins AC, Evans AJ, Wastie ML (1992) Bisphosphonate space measurement in Paget\u2019s disease of bone treated with APD. J Bone Miner Res 7:295\u2013301","journal-title":"J Bone Miner Res"},{"key":"852_CR33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","volume":"19","author":"H. Fleisch","year":"1998","unstructured":"Fleisch H (1998) Bisphosphonates: mechanisms of action. Endocr Rev 19:80\u2013100","journal-title":"Endocr Rev"},{"key":"852_CR34","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.0601643103","volume":"103","author":"K.L. Kavanagh","year":"2006","unstructured":"Kavanagh KL, Guo K, Dunford JE, Wu X, Knapp S, Ebetino FH, Rogers MJ, Russell RG, Oppermann U (2006) The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc Natl Acad Sci U S A 103:7829\u20137834","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Bone and Mineral Metabolism"],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-008-0852-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-008-0852-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-008-0852-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:14:22Z","timestamp":1559110462000},"score":1.0,"issued":{"date-parts":[[2008,11]]},"references-count":34,"journal-issue":{"published-print":{"date-parts":[[2008,11]]},"issue":"6"},"alternative-id":["852"],"URL":"http:\/\/dx.doi.org\/10.1007\/s00774-008-0852-6","relation":{"cites":[]},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":["Endocrinology, Diabetes and Metabolism","Endocrinology","Orthopedics and Sports Medicine","General Medicine"]}],"items-per-page":30,"query":{"start-index":0,"search-terms":null}}}